
<html lang="en"     class="pb-page"  data-request-id="190fdf87-bf4b-44aa-85da-1c3f86f1dd34"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.9b01605;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2020.63.issue-1;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration" /></meta><meta name="dc.Creator" content="Philippe  Panchaud" /></meta><meta name="dc.Creator" content="Jean-Philippe  Surivet" /></meta><meta name="dc.Creator" content="Stefan  Diethelm" /></meta><meta name="dc.Creator" content="Anne-Catherine  Blumstein" /></meta><meta name="dc.Creator" content="Jean-Christophe  Gauvin" /></meta><meta name="dc.Creator" content="Loïc  Jacob" /></meta><meta name="dc.Creator" content="Florence  Masse" /></meta><meta name="dc.Creator" content="Gaëlle  Mathieu" /></meta><meta name="dc.Creator" content="Azely  Mirre" /></meta><meta name="dc.Creator" content="Christine  Schmitt" /></meta><meta name="dc.Creator" content="Michel  Enderlin-Paput" /></meta><meta name="dc.Creator" content="Roland  Lange" /></meta><meta name="dc.Creator" content="Carmela  Gnerre" /></meta><meta name="dc.Creator" content="Swen  Seeland" /></meta><meta name="dc.Creator" content="Charlyse  Herrmann" /></meta><meta name="dc.Creator" content="Hans H.  Locher" /></meta><meta name="dc.Creator" content="Peter  Seiler" /></meta><meta name="dc.Creator" content="Daniel  Ritz" /></meta><meta name="dc.Creator" content="Georg  Rueedi" /></meta><meta name="dc.Description" content="LpxC inhibitors were optimized starting from lead compounds with limited efficacy and solubility and with the goal to provide new options for the treatment of serious infections caused by Gram-nega..." /></meta><meta name="Description" content="LpxC inhibitors were optimized starting from lead compounds with limited efficacy and solubility and with the goal to provide new options for the treatment of serious infections caused by Gram-nega..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 5, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01605" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01605" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01605" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01605" /></link>
        
    
    

<title>Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01605" /></meta><meta property="og:title" content="Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0017.jpeg" /></meta><meta property="og:description" content="LpxC inhibitors were optimized starting from lead compounds with limited efficacy and solubility and with the goal to provide new options for the treatment of serious infections caused by Gram-negative pathogens in hospital settings. To enable the development of an aqueous formulation for intravenous administration of the drug at high dose, improvements in both solubility and antibacterial activity in vivo were prioritized early on. This lead optimization program resulted in the discovery of compounds such as 13 and 30, which exhibited high solubility and potent efficacy against Gram-negative pathogens in animal infection models." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01605"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01605">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01605&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01605&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01605&amp;href=/doi/10.1021/acs.jmedchem.9b01605" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 88-102</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01604" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00293" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Philippe Panchaud</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philippe Panchaud</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +41 58 844 00 00. E-mail: <a href="/cdn-cgi/l/email-protection#c2b2aaabaeabb2b2a7ecb2a3aca1aaa3b7a682aba6adb0b1aba3eca1adaf"><span class="__cf_email__" data-cfemail="77071f1e1b1e07071259071619141f160213371e131805041e165914181a">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Panchaud">Philippe Panchaud</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7823-7639" title="Orcid link">http://orcid.org/0000-0001-7823-7639</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean-Philippe Surivet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-Philippe Surivet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Philippe++Surivet">Jean-Philippe Surivet</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3505-2025" title="Orcid link">http://orcid.org/0000-0002-3505-2025</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefan Diethelm</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan Diethelm</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Diethelm">Stefan Diethelm</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anne-Catherine Blumstein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anne-Catherine Blumstein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anne-Catherine++Blumstein">Anne-Catherine Blumstein</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean-Christophe Gauvin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-Christophe Gauvin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Christophe++Gauvin">Jean-Christophe Gauvin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Loïc Jacob</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Loïc Jacob</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lo%C3%AFc++Jacob">Loïc Jacob</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Florence Masse</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Florence Masse</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Florence++Masse">Florence Masse</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gaëlle Mathieu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gaëlle Mathieu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ga%C3%ABlle++Mathieu">Gaëlle Mathieu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Azely Mirre</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Azely Mirre</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Azely++Mirre">Azely Mirre</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christine Schmitt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christine Schmitt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Schmitt">Christine Schmitt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michel Enderlin-Paput</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michel Enderlin-Paput</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Enderlin-Paput">Michel Enderlin-Paput</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roland Lange</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roland Lange</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roland++Lange">Roland Lange</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carmela Gnerre</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carmela Gnerre</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carmela++Gnerre">Carmela Gnerre</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Swen Seeland</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Swen Seeland</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Swen++Seeland">Swen Seeland</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charlyse Herrmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charlyse Herrmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charlyse++Herrmann">Charlyse Herrmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hans H. Locher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hans H. Locher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hans+H.++Locher">Hans H. Locher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter Seiler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Seiler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Seiler">Peter Seiler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Ritz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Ritz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Ritz">Daniel Ritz</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Georg Rueedi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Georg Rueedi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Georg++Rueedi">Georg Rueedi</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01605&amp;href=/doi/10.1021%2Facs.jmedchem.9b01605" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 88–102</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 5, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 September 2019</li><li><span class="item_label"><b>Published</b> online</span>5 December 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 January 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01605" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01605</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D88%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPhilippe%2BPanchaud%252C%2BJean-Philippe%2BSurivet%252C%2BStefan%2BDiethelm%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D1%26contentID%3Dacs.jmedchem.9b01605%26title%3DOptimization%2Bof%2BLpxC%2BInhibitor%2BLead%2BCompounds%2BFocusing%2Bon%2BEfficacy%2Band%2BFormulation%2Bfor%2BHigh%2BDose%2BIntravenous%2BAdministration%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D102%26publicationDate%3DJanuary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01605"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1429</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01605" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Panchaud&quot;},{&quot;first_name&quot;:&quot;Jean-Philippe&quot;,&quot;last_name&quot;:&quot;Surivet&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Diethelm&quot;},{&quot;first_name&quot;:&quot;Anne-Catherine&quot;,&quot;last_name&quot;:&quot;Blumstein&quot;},{&quot;first_name&quot;:&quot;Jean-Christophe&quot;,&quot;last_name&quot;:&quot;Gauvin&quot;},{&quot;first_name&quot;:&quot;Loïc&quot;,&quot;last_name&quot;:&quot;Jacob&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;Masse&quot;},{&quot;first_name&quot;:&quot;Gaëlle&quot;,&quot;last_name&quot;:&quot;Mathieu&quot;},{&quot;first_name&quot;:&quot;Azely&quot;,&quot;last_name&quot;:&quot;Mirre&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Schmitt&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Enderlin-Paput&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;Lange&quot;},{&quot;first_name&quot;:&quot;Carmela&quot;,&quot;last_name&quot;:&quot;Gnerre&quot;},{&quot;first_name&quot;:&quot;Swen&quot;,&quot;last_name&quot;:&quot;Seeland&quot;},{&quot;first_name&quot;:&quot;Charlyse&quot;,&quot;last_name&quot;:&quot;Herrmann&quot;},{&quot;first_name&quot;:&quot;Hans&quot;,&quot;last_name&quot;:&quot;H. Locher&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Seiler&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Ritz&quot;},{&quot;first_name&quot;:&quot;Georg&quot;,&quot;last_name&quot;:&quot;Rueedi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;88-102&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01605&quot;},&quot;abstract&quot;:&quot;LpxC inhibitors were optimized starting from lead compounds with limited efficacy and solubility and with the goal to provide new options for the treatment of serious infections caused by Gram-negative pathogens in hospital settings. To enable the development of an aqueous formulation for intravenous administration of the drug at high dose, improvements in both solubility and antibacterial activity in vivo were prioritized early on. This lead optimization program resulted in the discovery of compounds such as 13 and 30, which exhibited high solubility and potent efficacy against Gram-negative pathogens in animal infection models.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01605&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01605" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01605&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01605" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01605&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01605" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01605&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01605&amp;href=/doi/10.1021/acs.jmedchem.9b01605" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01605" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01605" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01605%26sid%3Dliteratum%253Aachs%26pmid%3D31804829%26genre%3Darticle%26aulast%3DPanchaud%26date%3D2020%26atitle%3DOptimization%2Bof%2BLpxC%2BInhibitor%2BLead%2BCompounds%2BFocusing%2Bon%2BEfficacy%2Band%2BFormulation%2Bfor%2BHigh%2BDose%2BIntravenous%2BAdministration%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D1%26spage%3D88%26epage%3D102%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291676" title="Antibacterial activity">Antibacterial activity</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/jmcmar.2020.63.issue-1/20200109/jmcmar.2020.63.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01605&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">LpxC inhibitors were optimized starting from lead compounds with limited efficacy and solubility and with the goal to provide new options for the treatment of serious infections caused by Gram-negative pathogens in hospital settings. To enable the development of an aqueous formulation for intravenous administration of the drug at high dose, improvements in both solubility and antibacterial activity in vivo were prioritized early on. This lead optimization program resulted in the discovery of compounds such as <b>13</b> and <b>30</b>, which exhibited high solubility and potent efficacy against Gram-negative pathogens in animal infection models.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30053" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30053" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Infections caused by multidrug-resistant (MDR) Gram-negative bacteria are nowadays considered as one of the greatest threats to global health.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> In particular, the incidence of infections caused by resistant pathogens such as <i>Acinetobacter</i>, <i>Pseudomonas aeruginosa</i> (Pae), and Enterobacteriaceae including <i>Klebsiella pneumoniae</i> (Kpn) and <i>Escherichia coli</i> (Eco), is increasing at a steady and alarming pace.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Development of novel antibiotics active against these MDR Gram-negative bacteria (GNB) is urgently needed to provide new therapeutic options for difficult-to-treat infections and to avoid antimicrobial resistance (AMR), jeopardizing modern medical practice such as general intensive care, joint replacement, transplant surgery, and cancer therapy.</div><div class="NLM_p">LpxC has drawn attention as a promising target for new antibiotic discovery ever since specific inhibitors exhibiting potent growth inhibition of Pae and Enterobacteriaceae were discovered.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> In addition, such antibiotics with novel mechanisms of action may overcome cross-resistance with marketed antibiotics because no LpxC inhibitors are currently used in clinical settings. LpxC (UDP-3-<i>O</i>-((<i>R</i>)-3-hydroxymyristoyl)-<i>N</i>-acetylglucosamine deacetylase; EC 3.5.1.108) is a zinc-dependent enzyme localized in the cytosol of GNB.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> It catalyzes the first committed step in the biosynthesis of lipid A, a major component of lipopolysaccharides (LPS), and is essential for Gram-negative outer membrane integrity and cell envelope biogenesis.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The gene encoding LpxC is broadly distributed across the genomes of GNB, while no homologues have been found in genomes of Gram-positive bacteria and mammals. This offers the possibility of developing a selective treatment, which would avoid promoting resistance development in Gram-positive organisms and be devoid of side effects linked to the inhibition of a homologous human target.</div><div class="NLM_p">In the <a href="https://doi.org/10.1021/10.1021/acs.jmedchem.9b01604">companion paper</a>,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> we reported the discovery of new LpxC inhibitors <b>1</b>–<b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which exhibited dose-dependent efficacy in a mouse thigh infection model. Even though the results of these proof-of-concept studies were encouraging, daily doses of 150 mg/kg did not lead to a reduction of bacterial load below that at treatment start. Similarly, methylsulfone hydroxamate derivatives reported by Pfizer, such as <b>4</b>, suffered from limited free exposures in rodents, mainly due to their high plasma clearance.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The optimization strategy reported in this latter case focused on lowering the human predicted dose by reducing plasma protein binding, which successfully yielded compounds such as <b>5</b> with improved free exposures and efficacy whereas clearance remained moderate to high.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Methylsulfone hydroxamate LpxC inhibitors reported by Idorsia (<b>1</b>–<b>3</b>) and Pfizer (<b>4</b>,<b>5</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01605&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds with low clearance in humans are usually preferred because they minimize the therapeutic doses needed, apart from the case described above that represents an exception. In addition, low clearance in animals is also advantageous for preclinical development because toxicology studies are conducted at exposure levels that are multiples of those estimated for human efficacy. The identification of compounds that can be formulated as concentrated solutions for conducting such toxicology studies represents an additional challenge in the context of development of antibiotics for Gram-negative pathogens, where patients are typically treated in hospitals with high daily doses intravenously.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p last">Starting from the reported lead compounds <b>1</b>–<b>3</b>, we aimed at improving antibacterial activity in vivo while concomitantly ensuring high solubility in a vehicle adequate for future safety studies. We took advantage of the various leads’ structural features to follow a two-pronged approach. Starting from lead compound <b>1</b>, we improved the intrinsic solubility and formulability by using the potential of its amino moiety for ionization. In parallel, we targeted improving efficacy and metabolic stability for lead compounds <b>2</b> and <b>3</b>, while their hydroxy group represented a potential handle to attach a solubilizing moiety that would enable the development of a prodrug approach later on if needed.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Antibacterial Activity, Solubility, and p<i>K</i><sub>a</sub></h3><div class="NLM_p">Compound <b>1</b> was regarded as a particularly appealing starting point for investigating the solubility and formulability of this series of LpxC compounds. As previously seen in X-ray structures of compounds from this chemical series, the terminal substituent on the distal alkyne lies on the outside of the LpxC enzyme, which allowed for structural modification without detrimental effects on the enzyme binding affinity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The compound showed moderate solubility at pH 4, 7, and 9 and potent antibacterial activity with MICs of <1 μg/mL against the three strains tested (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). With a measured log <i>D</i> of 0.7 at pH 7.4, <b>1</b> was relatively polar among the compounds evaluated. The various p<i>K</i><sub>a</sub>s of the compound were determined to investigate the impact of ionization on solubility. The primary amine turned out to be weakly basic (p<i>K</i><sub>a</sub> 6.5) and the hydroxamic acid weakly acidic (p<i>K</i><sub>a</sub> 7.5). Therefore, several ionized species exist under equilibrium at physiological pH, which may limit the potential to formulate the compound at high concentrations. The target concentration for formulation was set at 25 mg/mL at a pH ranging from 4.5 to 8.5 to avoid local tolerance issues at the injection site.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Given the p<i>K</i><sub>a</sub> values of <b>1</b>, the pH of a suitable formulation would have to be <4.5 in order to allow for sufficient solubility with >99% of the compound in the protonated state. Therefore, we decided to look for compounds which possess a more basic amine because a higher p<i>K</i><sub>a</sub> would allow complete protonation of the amine at a pH closer to physiological conditions, thus facilitating the preparation of concentrated formulations.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Exploration of Side Chains Containing an Amine Function</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0005.gif" alt="" id="GRAPHIC-d7e455-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0006.gif" alt="" id="gr5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last"><i>E. coli</i> ATCC 25922; <i>K. pneumoniae</i> T 6474, QR and ESBL; <i>P. aeruginosa</i> ATCC 27853.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">DSF on isolated enzyme, determined at 25 μM compound concentration.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">p<i>K</i><sub>a</sub> of the hydroxamic acid varied between 7.3 and 7.7.</p></div></div><div></div></div><div class="NLM_p">Addition of methyl groups to <b>1</b> resulted in derivatives <b>6</b> and <b>7</b>, which displayed comparable antibacterial activity despite having slightly increased binding affinity for the enzymes (Δ<i>T</i><sub>m</sub> values, determined by DSF). However, their solubility decreased in line with the log <i>D</i> increase.</div><div class="NLM_p">The introduction of an extra carbon atom in <b>8</b> resulted in a significant p<i>K</i><sub>a</sub> shift with a more basic nitrogen (p<i>K</i><sub>a</sub> 9.2), which would be almost fully protonated under physiological conditions. This was reflected in the solubility and log <i>D</i> measurements. Unfortunately, compound <b>8</b> had almost completely lost its antibacterial activity even though it had retained significant binding to the enzymes (Δ<i>T</i><sub>m</sub>). It was hypothesized that the basic primary amine may lead to a reduced uptake into the GNBs under investigation because the MIC shifts between the WT Pae strain and the isogenic efflux mutant were comparable for all compounds shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> (4–8-fold shift, Supporting Information (SI), <a href="/doi/suppl/10.1021/acs.jmedchem.9b01605/suppl_file/jm9b01605_si_001.pdf" class="ext-link">Table S-1</a>).</div><div class="NLM_p">Various nitrogen-containing rings were also considered as side chains. Hydroxypiperidine derivative <b>9</b> displayed moderate antibacterial activity against the three strains as well as very good solubility at all pHs but its p<i>K</i><sub>a</sub> was identical to that of <b>1</b>, thus preventing us from fully exploiting the nitrogen atom’s potential for ionization. An inversion of the piperidine ring as in <b>10</b> led to a p<i>K</i><sub>a</sub> increase but still resulted in a weaker antibacterial activity. Although critical for achieving potent activity against these three bacteria, neither the basicity nor the location of the nitrogen influenced the binding to the enzyme. Modification with a fluorine<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> or oxetane<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> substituent in <b>11</b> and <b>12</b> resulted in a stepwise decrease in the p<i>K</i><sub>a</sub> along with variable effects on lipophilicity and solubility, but this did not result in recovering the targeted level of antibacterial activity. Only <b>13</b>, with its smaller azetidine ring, displayed antibacterial activity below 1 μg/mL against the three strains, was very soluble at all pHs tested, and possessed a basic p<i>K</i><sub>a</sub> of 8.4, which was deemed ideal to allow sufficient solubility for developing a concentrated formulation suitable for iv dosing. Surprisingly, it had an MIC of 0.5 μg/mL against Pae despite having the lowest Δ<i>T</i><sub>m</sub> among the compounds tested, suggesting again that the antibacterial potency is driven not only by target potency but also by drug accumulation in the cytoplasm.</div><div class="NLM_p">The potential of the azetidine side chains was further explored (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Because amides are usual metabolites resulting from aldehyde oxidase-mediated reduction of hydroxamic acids, we first checked whether the presence of the hydroxamic acid moiety was indeed required for activity. As expected, the corresponding amide derivative <b>14</b> did not show any inhibitory activity and did not bind to the enzymes. Then, the effect of the azetidine substitution on antibacterial activity and solubility was investigated.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Exploration of the Azetidine Side Chain Substitution</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0007.gif" alt="" id="GRAPHIC-d7e605-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0008.gif" alt="" id="gr6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last"><i>E. coli</i> ATCC 25922; <i>K. pneumoniae</i> T 6474, QR and ESBL; <i>P. aeruginosa</i> ATCC 27853.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">DSF on isolated enzyme, determined at 25 μM compound concentration.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">p<i>K</i><sub>a</sub> of the hydroxamic acid varied between 7.2 and 7.7.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Amide instead of hydroxamic acid.</p></div></div><div></div></div><div class="NLM_p last">Unsubstituted azetidine <b>15</b> retained some level of antibacterial activity, notably against Pae, despite the basic p<i>K</i><sub>a</sub> and the high polarity as indicated by the negative log <i>D</i>. Oxetane derivative <b>16</b> displayed MICs comparable to those of <b>13</b> but was significantly less soluble at pH 7, likely due to the reduced nitrogen basicity. In comparison, the p<i>K</i><sub>a</sub> increased with the two fluorinated azetidines <b>17</b> and <b>18</b>. While the former had overall properties comparable to <b>16</b> despite its lower affinity to the enzymes, the latter had antibacterial activity and solubility that were not satisfactory. When the fluorine was present on the substituent of the azetidine nitrogen, as in <b>19</b>, MICs improved but the solubility at pH 7 remained limited, in line with the p<i>K</i><sub>a</sub> and log <i>D</i>. An attempt to further modify the antibacterial activity by modulating log <i>D</i> and p<i>K</i><sub>a</sub> with an additional fluorine atom<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> in <b>20</b> proved unsuccessful. As expected, it led to increased log <i>D</i> and concomitantly decreased p<i>K</i><sub>a</sub>, but the antibacterial activity did not improve. Ethyl-substituted analogue <b>21</b> displayed overall properties comparable to those of <b>13</b>, while isopropyl derivative <b>22</b> exhibited higher log <i>D</i> and lower MICs against Enterobacteriaceae. Surprisingly, the MIC against Pae was not negatively affected by the increased lipophilicity. Even though <b>22</b> had a p<i>K</i><sub>a</sub> in the desired range, it suffered from limited solubility at pH 7 and 9. Hydroxy-containing side chains were also tolerated, as highlighted by <b>23</b> and <b>24</b>. These derivatives displayed overall properties comparable to those of <b>13</b>, although a somewhat slightly lower p<i>K</i><sub>a</sub>. One advantage of such derivatives may be the possible use of the hydroxy function as a handle to attach a promoiety in using a prodrug approach, which could be an option to reach higher concentrations in formulations if needed. Interestingly, the slightly less active amide <b>25</b> was highly soluble over the entire pH range tested even though it did not contain a protonable nitrogen. In summary, the azetidine ring has been shown to be a privileged motif that allows combining potent antibacterial activity and high solubility. Several compounds of interest were therefore progressed into in vivo evaluation (vide infra).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Metabolic Stability</h3><div class="NLM_p">The other chemical series reported in the companion paper,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> featured a hydroxymethyl substituent on the cyclopropyl moiety in place of the amino group found in <b>1</b>. These early leads <b>2</b> and <b>3</b> also exhibited dose-dependent efficacy in the murine thigh infection model, but net static efficacy over 24 h was not achieved even at relatively high doses. To improve the efficacy in this model, one could focus on improving the intrinsic antibacterial activity (MIC) and/or the exposure (PK). It had already been reported that most of the metabolism of methylsulfone derivatives such as <b>4</b> occur on the hydroxamic acid moiety via glucuronide formation and aldehyde oxidase-mediated reduction to the corresponding amide.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> To gain a more detailed understanding of our compounds’ metabolism, and the impact of the solvent-exposed groups in particular, a metabolite identification study was performed on a compound related to <b>2</b> and possessing the same cyclopropyl substitution. Upon incubation in suspended fresh rat hepatocytes, a glucuronide and the corresponding amide were indeed observed as expected. The hydroxymethyl side chain also appeared to be a metabolically labile spot, which, upon oxidation, gave the corresponding carboxylic acid in both rat microsomes and hepatocytes. We therefore decided to increase the sterics around the cyclopropyl moiety to block this metabolically labile site. The effects of these modifications on antibacterial activity and metabolic stability in vitro are reported in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Exploration of Side Chains Containing a Hydroxy Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0009.gif" alt="" id="GRAPHIC-d7e783-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0010.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last"><i>E. coli</i> ATCC 25922; <i>K. pneumoniae</i> T 6474, QR and ESBL; <i>P. aeruginosa</i> ATCC 27853.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Intrinsic clearance in μL/(min·10<sup>6</sup> cells) measured in fresh rat hepatocytes in suspension. The fraction unbound of compounds in media used for all Cl<sub>int</sub> investigations were all in a similar range.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Intrinsic clearance in μL/(min·mg) measured in rat liver microsomes.</p></div></div><div></div></div><div class="NLM_p last">As reported in the companion paper,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> the difference in the stereochemistry of the cyclopropyl ring in <b>2</b> and <b>26</b> impacted neither the MIC nor the Cl<sub>int</sub> measured in vitro in rat hepatocytes and microsomes. However, when the hydroxymethyl group was appended to a different position on the cyclopropane ring as in <b>3</b>, the antibacterial activity was slightly reduced and hepatocytes Cl<sub>int</sub> slightly decreased together with a concomitant increase in metabolic liability in microsomes. The presence of a methyl group in <b>27</b>, which displayed MICs comparable to those of <b>2</b>, resulted in an increase of about 3-fold in Cl<sub>int</sub> in hepatocytes but not in microsomes, potentially indicating an enhanced glucuronidation. The opposite trend was observed with an additional fluorine atom at the same position, and both diastereomers <b>28</b> and <b>29</b> displayed a slightly lower Cl<sub>int</sub>. This additional atom had no impact on the antibacterial activity when compared to <b>2</b> and <b>26</b>. Incorporation of an additional hydroxymethyl unit on this substituent led to <b>30</b> and <b>31</b>, which, in addition to improved metabolic stability, also displayed excellent solubility.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Pharmacology</h3><div class="NLM_p">Hydroxy-containing derivatives with acceptable Cl<sub>int</sub> values as well as azetidine analogues showing the targeted antibacterial activity in vitro were assessed for efficacy against <i>E. coli</i> in the neutropenic murine thigh infection model after subcutaneous administration (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The fluorinated derivative <b>29</b> reduced CFU below net stasis, i.e., below the level measured at treatment start 2 h after mice were infected, and exhibited significantly higher efficacy in this model as compared to the previous lead compounds <b>2</b> and <b>3</b>. While the 3-fold increase in free AUC could explain the higher efficacy compared to <b>2</b>, <b>29</b> also displayed a stronger CFU reduction than <b>3</b> despite a 2-fold lower free AUC and comparable MIC. Diol <b>30</b> also displayed an improved efficacy and a larger free AUC. With its roughly 5-fold higher free AUC, the soluble azetidine <b>13</b> proved more efficacious than its previous amine lead compound <b>1</b>. Fluoroethyl derivative <b>19</b> displayed efficacy below net stasis, comparable to that of <b>13</b>, with the 8-fold improved MIC of <b>19</b> over <b>13</b> compensating for its 6-fold reduced free AUC. Finally, the two hydroxy derivatives <b>23</b> and <b>24</b> revealed different results. While the efficacy and MIC of <b>23</b> was comparable to that of <b>13</b>, the free exposure of <b>24</b> was low and did only result in marginal reduction of the bacterial burden in vivo.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Efficacy and Exposure of Selected Derivatives in Mice</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0011.gif" alt="" id="GRAPHIC-d7e944-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0012.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last"><i>E. coli</i> ATCC 25922.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Mice were treated sc at 150 mg/kg starting at 2 h post infection and sacrificed at 24 h post infection. Median Δlog<sub>10</sub>CFU/thigh of animal treated with compounds compared to CFU at treatment start is reported.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Determined at 1 μM compound concentration.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">AUC values originated from PK studies performed in mouse dosed sc at 150 mg/kg, except for <b>2</b>, for which the AUC was extrapolated from a sc dosing at 50 mg/kg.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> ADME Properties</h3><div class="NLM_p">The compounds that exhibited interesting efficacy in the murine infection model were further characterized in rats for their PK properties after intravenous dosing, with the goal to investigate the correlation between in vitro and in vivo clearances as a first step toward human PK modeling. Fluorinated cyclopropyl <b>29</b> displayed a 7-fold lower unbound clearance compared to <b>2</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). It showed a proportionally higher free exposure, highlighting the positive effect of the fluorine. Diol <b>30</b> displayed the lowest clearance among all hydroxy derivatives. Among the compounds with amine side chains, <b>13</b> had lower unbound clearance than <b>1</b> in rats. This was reflected in the in vitro Cl<sub>int</sub> data from hepatocytes but not liver microsomes. Data from hepatocytes are therefore better suited to predict in vivo clearance, consistent with the important role played by phase II metabolism for this series of compounds. The more lipophilic fluoroethyl derivative <b>19</b> displayed higher clearance, while the hydroxy-containing azetidine derivative <b>23</b> was comparable to <b>13</b> overall. In general, the more metabolically stable the compound was in rat hepatocytes in vitro, the lower its unbound clearance and the higher its free AUC in vivo. Given the intrinsic clearance shown in human in vitro systems, a lower metabolic clearance is expected in human as compared to that measured in animals.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro and Rat PK Parameters of Selected Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0013.gif" alt="" id="GRAPHIC-d7e1018-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0014.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Intrinsic clearance in μL/(min·10<sup>6</sup> cells) measured in fresh rat hepatocytes in suspension. All Cl<sub>int</sub> were determined at 1 μM compound concentration, and the fraction unbound of compounds in media were all in a similar range.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Intrinsic clearance in μL/(min·mg) measured in rat liver microsomes.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Intrinsic clearance in μL/(min·10<sup>6</sup> cells) measured in cryopreserved human hepatocytes in suspension.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Intrinsic clearance in μL/(min·mg) measured in human liver microsomes.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Determined at 1 μM compound concentration.</p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last">Rats were dosed iv at 10 mg/kg; Cl<sub>u</sub>: unbound clearance calculated by correcting total Cl (in parentheses) with the free fraction in plasma.</p></div><div class="footnote" id="t5fn7"><sup><sup>g</sup></sup><p class="last">Calculated from iv PK at 50 mg/kg.</p></div></div><div></div></div><div class="NLM_p last">Additional in vitro investigations on reactive metabolite formation and drug–drug interactions were performed. Upon incubation of the compounds at 10 μM with human liver microsomes, the rates of trapping of reactive entities by dansyl glutathione were in all instances lower than 100 pmol/mg·h. The compounds did not inhibit any of the major cytochromes P450 enzymes CYP3A4/2C9/2D6 (IC<sub>50</sub> > 50 μM), and neither did <b>29</b>, <b>30</b>, <b>1</b>, <b>13</b>, and <b>23</b> activate the human pregnane X receptor (PXR) at concentration up to 30 μM (<b>2</b> and <b>19</b> not tested in this latter assay).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Antibacterial Activity on an Extended Panel of Strains</h3><div class="NLM_p">Five compounds were further evaluated against a panel of recent clinical isolates, including drug-resistant pathogens, such as fluoroquinolone- or carbapenem-resistant strains (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). All compounds showed potent activity against Enterobacteriaceae with MIC<sub>90</sub> values of ≤4 μg/mL and against Pae isolates with MIC<sub>90</sub> of ≤2 μg/mL. While excellent activity was observed against the respiratory-tract pathogen <i>Haemophilus influenzae</i>, there was no useful activity against <i>Acinetobacter baumannii</i> and <i>Moraxella catarrhalis</i>. This is in agreement with the published findings that in these GNB the activity of LpxC is dispensable for growth.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In addition, all compounds exhibited only weak binding affinity in DSF against an isolated <i>A. baumannii</i> enzyme (data not shown). Similarly, it is reasonable to assume that it is also the case for <i>Stenotrophomonas maltophila</i>. In summary, these compounds have an antibacterial spectrum that would be well suited for the treatment of serious infections caused by GNB, especially Enterobacteriaceae and <i>P. aeruginosa</i>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. MIC<sub>90</sub> (μg/mL) of Selected Derivatives and Reference Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>Strains (<i>n</i>)</b></th><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center"><b>19</b></th><th class="colsep0 rowsep0" align="center"><b>23</b></th><th class="colsep0 rowsep0" align="center"><b>29</b></th><th class="colsep0 rowsep0" align="center"><b>30</b></th><th class="colsep0 rowsep0" align="center"><b>cipro<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></b></th><th class="colsep0 rowsep0" align="center"><b>tige<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></b></th><th class="colsep0 rowsep0" align="center"><b>imi<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C. freundii</i> (10)</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.125</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. aerogenes</i> (11)</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">0.03</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. cloacae</i> (10)</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">0.06</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i> (21)</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.25</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">>8</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. oxytoca</i> (9)</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">0.125</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">≤0.016</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i> (21)</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">>8</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">>16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>M. morganii</i> (10)</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">0.25</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">≤0.016</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. mirabilis</i> (10)</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.125</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. marcescens</i> (11)</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">0.25</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">0.25</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumanii</i> (15)</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>8</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">>16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>B. cepacia</i> (11)</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>H. influenzae</i> (9)</td><td class="colsep0 rowsep0" align="center">≤0.03</td><td class="colsep0 rowsep0" align="center">≤0.03</td><td class="colsep0 rowsep0" align="center">≤0.03</td><td class="colsep0 rowsep0" align="center">≤0.03</td><td class="colsep0 rowsep0" align="center">≤0.03</td><td class="colsep0 rowsep0" align="center">≤0.016</td><td class="colsep0 rowsep0" align="center">0.25</td><td class="colsep0 rowsep0" align="center">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>M. catarrhalis</i> (10)</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> (16)</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">>8</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. maltophilia</i> (10)</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">>16</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">>16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Ciprofloxacin.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Tigecycline.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Imipenem.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Formulation Investigations</h3><div class="NLM_p">The identification of a formulation suitable for toxicity studies often represents a challenge in the field of antibacterial compounds targeting GNB because single doses of ≥1 g are required for human use, and multiples of the predicted human exposure are needed in animals. Highly concentrated formulations are therefore required because the volume that can be injected is limited, and only vehicles that do not lead to any tolerability or toxicity issues on their own can be used.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">We decided to test our compounds at various concentrations in an aqueous solution containing 5% mannitol as the only excipient for osmolarity adjustment and modify the pH to maximize solubility. The lowest acceptable pH was set at pH 4.5 to avoid local tolerance issues at the injection site. As the ionization of compounds comprising a hydroxy-containing side chain devoid of any basic amine takes place at basic pH by deprotonation of the hydroxamic acid, the upper pH threshold was set at pH 8.5. Formulations trials were conducted at concentrations of 1, 5, 10 and 25–30 mg/mL, and the highest concentration for each derivative where a clear solution was obtained is reported in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>. Azetidines <b>13</b>, <b>19</b>, and <b>23</b> could be successfully formulated at 25–30 mg/mL under acidic conditions. For the latter two, slightly turbid formulations were obtained at the highest concentrations. Filtration through a 0.22 μm PVDF filter yielded clear solutions, which showed the expected concentration after HPLC analysis. Diol <b>30</b> also turned out to be soluble at high concentration in a slightly basic formulation, whereas the limited solubility of <b>29</b> prevented clear solutions at concentration >1 mg/mL.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Formulations Resulting in a Clear Solution in 5% Mannitol/Water</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>Cmpd</b></th><th class="colsep0 rowsep0" align="center"><b>Concentration (mg/mL)</b></th><th class="colsep0 rowsep0" align="center"><b>pH</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">8.2</td></tr></tbody></table></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>6</b>, <b>8</b>, <b>9</b>, <b>11</b>, <b>16</b>, <b>18</b>, <b>24</b>, and <b>27</b>–<b>31</b> were prepared by reacting alkyne <b>32</b> and halo-alkynes <b>33a</b>–<b>m</b> in a Cadiot–Chodkiewicz cross-coupling reaction<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> followed by cleavage of the THP protecting group under suitable acidic conditions, using either hydrochloric acid in a 9:1 mixture of methanol and water, or PPTS in ethanol (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> Alternatively, coupling alkyne <b>32</b> with iodoalkynes <b>33n</b>,<b>o</b> in a Sonogashira reaction gave <b>10</b>, respectively <b>12</b>, after deprotection.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Derivatives Using Cadiot–Chodkiewicz and Sonogashira Coupling<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01605&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CuCl, NH<sub>2</sub>OH·HCl, <i>n</i>-BuNH<sub>2</sub>, 0 °C–rt, 2 h; (b) HCl, 9:1 MeOH/H<sub>2</sub>O, rt, 1 h; (c) PPTS, EtOH, 80 °C, 2 h; (d) CuI, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Et<sub>3</sub>N, THF, 40 °C, 1 h.</p></p></figure><div class="NLM_p">The side chain of <b>7</b>, <b>17</b>, and <b>23</b> was functionalized by undergoing a reductive amination or a deprotection reaction under standard conditions before the final hydroxamic acid deprotection (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Derivatives <b>7</b>, <b>17</b>, and <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01605&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CuCl, NH<sub>2</sub>OH·HCl, <i>n</i>-BuNH<sub>2</sub>, 0 °C–rt, 2 h; (b) HCHO, NaBH(OAc)<sub>3</sub>, DCM, rt, 1–16 h; (c) HCl, 9:1 MeOH/H<sub>2</sub>O, rt, 1 h; (d) PPTS, EtOH, 80 °C, 2 h; (e) TBAF, THF, rt, 3 h.</p></p></figure><div class="NLM_p">The azetidine-containing derivatives <b>13</b>, <b>15</b>, <b>19</b>–<b>22</b>, and <b>25</b> were prepared from the common intermediate <b>34</b> resulting from Cadiot–Chodkiewicz cross-coupling reaction between <b>32</b> and <b>33r</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). An acidic treatment delivered <b>15</b>, whereas performing first a reductive alkylation with formaldehyde, acetaldehyde, or acetone (<b>35a</b>–<b>c</b>) or employing a nucleophilic substitution with iodo- or trifluoromethanesulfonate electrophiles (<b>36a</b> or <b>36b</b>), gave <b>13</b>, <b>21</b>–<b>22</b>, respectively, <b>19</b>, <b>20</b>. Finally, amide <b>25</b> was prepared under standard conditions upon reaction with acetic acid. The detailed synthesis of all bromo- and iodo-alkynes as well as amide <b>14</b> are described in the <a class="ref internalNav" href="#notes1" aria-label="Supporting Information">Supporting Information</a>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Azetidine Derivatives from Intermediate <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01605&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CuCl, NH<sub>2</sub>OH·HCl, <i>n</i>-BuNH<sub>2</sub>, 0 °C–rt, 2 h; (b) HCl, 9:1 MeOH/H<sub>2</sub>O, rt, 1 h; (c) NaBH(OAc)<sub>3</sub>, DCM, rt, 1–2 h; (d) DIPEA, THF, rt–reflux, 2–4 h; (e) AcOH, HATU, DIPEA, THF, rt, 18 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We successfully completed a lead optimization program focused on improving solubility and formulability parameters as well as antibacterial efficacy rather than simply in vitro potency. Focusing on solubility in addition to activity early in the lead optimization phase led to the discovery of a set of compounds fulfilling the targeted attributes, i.e., improved antibacterial activity against GNB that cause complicated urinary tract, intraabdominal space, or lower respiratory tract infections and improved properties for intravenous administration. In addition to displaying suitable physicochemical properties enabling the development of a formulation for intravenous administration of high doses, the compounds exhibited improved metabolic stability, resulting in lower clearance leading to promising efficacy in an animal infection model. A few of these compounds will be assessed further and results will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemistry</h3><div class="NLM_p"><b>1</b>, <b>2</b>, <b>3</b>, <b>26</b>, and <b>32</b> was prepared as described.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> All solvents and chemicals were used as purchased without further purification. Analytical TLC characterizations were performed with 0.2 mm plates: Merck, Silica gel 60 F254. Column chromatography (CC) were performed using Brunschwig 60A silica gel (0.032–0.63 mm) or using an ISCO CombiFlash system and prepacked SiO<sub>2</sub> cartridges, and the elution was performed with an appropriate gradient of the indicated solvents. Unless indicated otherwise, the gradient started from 100% of apolar solvent and stopped at 100% of the polar solvent. When the polar solvent was MeOH, 100% corresponded to a 90:10 mixture of DCM/MeOH. In cases of compounds containing a basic function (e.g., amine), 1% of NH<sub>4</sub>OH (25% aq) was added to the polar eluent(s). Prep-HPLCs were performed on XBridge Prep C18 columns from Waters. Eluents: A, H<sub>2</sub>O + 0.5% acidic or basic additive; B, MeCN; gradient, 5% B to 95% B over 5 min. Detection: UV/vis and/or MS and/or ELSD. Prep-HPLC (acidic): additive in A was HCO<sub>2</sub>H. Prep-HPLC (basic): additive in A was NH<sub>4</sub>OH (25% aq). Chiral prep-HPLC were performed on a ChiralPak AD-H column from Daicel. Column, 5 μm 30 × 250 mm. Eluent, heptane/EtOH 3:7; flow, 16 mL/min; detection, UV 224 nm. NMR spectra were recorded on a Bruker Ascend 500 (500 MHz for <sup>1</sup>H; 125 MHz for <sup>13</sup>C) spectrometer. Chemical shifts (δ) are reported in parts per million (ppm) relative to deuterated solvent as the internal standard (δH: CDCl<sub>3</sub>, 7.26 ppm; DMSO-<i>d</i><sub>6</sub>, 2.50 ppm); multiplicities, s = singlet, d = doublet, t = triplet, q = quadruplet, m = multiplet, br = broad signal; coupling constants are given in Hz. LC-HRMS were performed on Waters Acquity UPLC-MS; pump, Waters Acquity Binary, Solvent Manager; MS, SYNAPT G2MS; DAD, Acquity UPLC PDA detector; column, Acquity UPLC CSH C18 1.7 μm 2.1 mm × 50 mm from Waters, thermostated in the Acquity UPLC Column Manager at 60 °C. Eluents: A, H<sub>2</sub>O + 0.05% HCO<sub>2</sub>H; B, MeCN + 0.05% HCO<sub>2</sub>H; gradient, 2% B to 98% B over 2.0 min; flow, 0.6 mL/min; detection, UV 214 nm and MS; the retention time <i>t</i><sub><i>R</i></sub> is given in min. The purity of all final compounds was ≥95%. Chiral LC (method 1) were performed on a ChiralPak AY-H column from Daicel. Column, 5 μm 4.6 mm × 250 mm. Eluent, heptane/EtOH 3:7; flow, 0.8 mL/min; detection, UV 210 nm. Chiral LC (method 2) were performed on a ChiralPak IF column from Daicel. Column, 5 μm 4.6 mm × 250 mm. Eluent, MeCN/EtOH + 0.2% TFA 1:4; flow, 1.2 mL/min; detection, UV 210 nm. Other LC-MS were obtained under the following conditions: pump, Agilent G4220A binary gradient pump; MS detector, Thermo Finnigan MSQPlus or equivalent; DAD detector, Agilent G4212A; ELS detector, Sedere SEDEX 90; column, Zorbax SB-aq 3.5 μm 4.6 mm × 50 mm from Agilent, thermostated at 40 °C. Eluents: A, H<sub>2</sub>O + 0.04% TFA; B, MeCN; gradient, 25% B to 95% B (0.0 min −1.0 min), 95% B (1.0 min −1.45 min); flow, 4.5 mL/min; detection, UV 214 nm and MS; the retention time <i>t</i><sub><i>R</i></sub> is given in min. The number of decimals given for the corresponding [M + H<sup>+</sup>] peak(s) of each tested compound depends upon the accuracy of the LC-MS device used.</div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure 1 (Cadiot–Chodkiewicz Coupling)</h4><div class="NLM_p last">CuCl (0.2 equiv) was added to a solution of <i>n</i>-BuNH<sub>2</sub> (0.5 mL; 5.0 equiv) in water (1.5 mL) at rt. NH<sub>2</sub>OH hydrochloride (2.0 equiv) was added, and the solution was stirred at rt for 15 min. The terminal alkyne (1.0 mmol; 1.0 equiv) was added, and the solution was cooled to 0 °C. A solution of the bromoalkyne (1.2 equiv) in <i>n</i>-BuNH<sub>2</sub> (0.5 mL) was added, and the reaction mixture was stirred for 2 h and allowed to warm to rt during that time. In case the reaction was not complete at that stage, as many rounds of cooling the reaction mixture to 0 °C, adding bromoalkyne (0.05–0.2 equiv) followed by stirring at rt for 1 h as necessary were undertaken. Upon completion, the reaction mixture was diluted with water (20 mL) and extracted with EtOAc (3 × 15 mL). The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification of the residue gave the desired product.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> General Procedure 2 (OTHP Deprotection Using HCl in MeOH)</h4><div class="NLM_p last">To a solution of the THP-protected hydroxamic acid derivative (0.1 mmol) in MeOH (1.1 mL) and water (0.1 mL) was added a 2 M aq HCl solution (0.5 mL). The reaction proceeded at rt for 1 h. A 25% aq NH<sub>4</sub>OH solution was added until pH 8 was reached, and the resulting mixture was purified by prep-HPLC.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedure 3 (Reductive Amination)</h4><div class="NLM_p last">To a solution of the amine (0.1 mmol; 1.0 equiv) in DCM (1.0 mL) were added the aldehyde (1.1–3.0 equiv) and NaBH(OAc)<sub>3</sub> (2.0–6.0 equiv). The reaction mixture was stirred at rt and monitored by LC-MS. Upon reaction completion, a saturated aq NaHCO<sub>3</sub> solution (3 mL) was added. The two layers were separated, and the aqueous layer was extracted with 9:1 DCM/MeOH (3 × 3 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the residue gave the desired product.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Procedure 4 (OTHP Deprotection Using PPTS)</h4><div class="NLM_p last">To a solution of the THP-protected hydroxamic acid derivative (0.1 mmol) in EtOH (5 mL) was added PPTS (1.5 equiv). The reaction mixture was stirred at 80 °C for 2 h and concentrated under reduced pressure. Purification of the residue gave the desired product.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> General Procedure 5 (Bisalkyne Formation via Pd/Cu Catalysis)</h4><div class="NLM_p last">To the alkyne (1.0 mmol; 1.0 equiv), the iodoalkyne (1.1 equiv), CuI (0.2 equiv), and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.1 equiv) was added dry THF (0.8 mL) and Et<sub>3</sub>N (3.5 equiv) at rt under inert atmosphere (N<sub>2</sub>). The resulting reaction mixture was purged with N<sub>2</sub> for 5 min, stirred at 40 °C for 1 h, and concentrated under reduced pressure. Purification of the residue gave the desired product.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> General Procedure 6 (Azetidine Alkylation)</h4><div class="NLM_p last">To a suspension of the azetidine derivative (1.0 mmol; 1.0 equiv) in THF (10 mL) at 0 °C were added DIPEA (2.0 equiv) and the alkylating agent (1.5 equiv). The reaction mixture was stirred and monitored by LC-MS. Upon reaction completion, DCM (10 mL) and saturated aq NaHCO<sub>3</sub> solution (10 mL) were added. The two layers were separated, and the aqueous layer was extracted with DCM (2 × 10 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the residue gave the desired product.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure 7 (Silyl Ether Deprotection)</h4><div class="NLM_p last">To a solution of the silyl ether(1.0 mmol; 1.0 equiv) in THF (10 mL) at rt was added a 1 M TBAF solution in THF (2.0 equiv). The reaction mixture was stirred for 3 h, and most of the THF was removed under reduced pressure. EtOAc (20 mL) and water (20 mL) were added, and the two layers were separated. The aqueous layer was extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification of the residue gave the desired product.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (2<i>R</i>)-<i>N</i>-Hydroxy-2-methyl-4-(6-((1-(methylamino)cyclopropyl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-2-(methylsulfonyl)butanamide (<b>6</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (62% yield) from <b>32</b> (0.100 g; 0.23 mmol) and <b>33a</b> (0.070 g; 0.33 mmol), followed by general procedure 2 (62% yield). Purification by prep-HPLC (basic) gave <b>6</b> as a yellowish solid (0.039 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.91 (br s, 1H), 9.16 (br s, 1H), 7.54 (d, <i>J</i> = 0.9 Hz, 1H), 6.24 (d, <i>J</i> = 1.2 Hz, 1H), 4.42 (s, 2H), 3.48 (m, 1H), 3.38 (m, 1H), 3.05 (s, 3H), 2.72 (br s, 1H), 2.57 (m, 1H), 2.31 (d, <i>J</i> = 1.8 Hz, 3H), 1.96 (m, 1H), 1.51 (s, 3H), 0.95–0.90 (m, 2H), 0.87–0.81 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 130.9, 117.7, 108.9, 105.9, 87.4, 74.4, 72.4, 68.3, 65.1, 45.2, 39.5 (overlaid), 37.0, 33.5, 31.9, 31.0, 17.7 (2C), 13.4. MS (ESI, <i>m</i>/<i>z</i>): 433.0 [M + H<sup>+</sup>] for C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O<sub>5</sub>S; <i>t</i><sub><i>R</i></sub> = 0.52 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M +H<sup>+</sup>] calcd for C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O<sub>5</sub>S 433.1546, found 433.1552; <i>t</i><sub><i>R</i></sub> = 0.87 min.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (2<i>R</i>)-4-(6-((1-(Dimethylamino)cyclopropyl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>7</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (83% yield) from <b>32</b> (2.50 g; 5.90 mmol) and <b>33p</b><sup><b>10</b></sup> (1.43 g; 7.31 mmol), followed by general procedure 3 (66% yield) starting from the isolated amine (0.150 g; 0.30 mmol) using a 37% aq formaldehyde solution (0.06 mL; 0.77 mmol) and stirring at rt overnight, followed by general procedure 4 (47% yield). Purification by CC (DCM–MeOH) gave <b>7</b> as a yellowish solid (0.039 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.95 (s, 1H), 9.19 (s, 1H), 7.58 (m, 1H), 6.27 (m, 1H), 4.44 (s, 2H), 3.49 (m, 1H), 3.39 (m, 1H), 3.06 (s, 3H), 2.60 (m, 1H), 2.26 (s, 6H), 1.97 (m, 1H), 1.53 (s, 3H), 1.00–0.97 (m, 2H), 0.92–0.88 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 163.9, 150.4, 130.9, 117.8, 108.7, 105.9, 83.4, 74.2, 72.3, 68.3, 67.7, 45.2, 42.4 (2C), 39.5 (overlaid), 38.3, 37.0, 31.0, 18.4 (2C), 13.3. MS (ESI, <i>m</i>/<i>z</i>): 447.1 [M + H<sup>+</sup>] for C<sub>21</sub>H<sub>26</sub>N<sub>4</sub>O<sub>5</sub>S; <i>t</i><sub><i>R</i></sub> = 0.54 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>21</sub>H<sub>26</sub>N<sub>4</sub>O<sub>5</sub>S 447.1702, found 447.1712; <i>t</i><sub><i>R</i></sub> = 0.95 min.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>R</i>)-4-(6-((1-(Aminomethyl)cyclopropyl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>8</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (80% yield) from <b>32</b> (0.100 g; 0.24 mmol) and <b>33b</b> (0.073 g; 0.35 mmol), followed by general procedure 2 (49% yield). Purification by prep-HPLC (basic) gave <b>8</b> as a white solid (0.040 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 7.53 (s, 1H), 6.23 (d, <i>J</i> = 1.2 Hz, 1H), 4.42 (s, 2H), 3.53–3.44 (m, 1H), 3.42–3.34 (m, 1H), 3.05 (s, 3H), 2.62–2.54 (m, 3H), 2.00–1.91 (m, 1H), 1.51 (s, 3H), 0.91–0.83 (m, 4H), hydroxamic acid OH and NH as well as primary amine NH<sub>2</sub> missing. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.7, 150.4, 130.9, 117.6, 108.9, 105.9, 89.3, 74.9, 70.6, 68.3, 62.5, 47.9, 45.2, 39.5 (overlaid), 37.0, 31.0, 16.1, 14.0 (2C), 13.4. MS (ESI, <i>m</i>/<i>z</i>): 474.0 [M + MeCN + H<sup>+</sup>] for C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O<sub>5</sub>S; <i>t</i><sub><i>R</i></sub> = 0.53 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O<sub>5</sub>S 433.1546, found 433.1551; <i>t</i><sub><i>R</i></sub> = 0.88 min.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (2<i>R</i>)-<i>N</i>-Hydroxy-4-(6-(5-(4-hydroxypiperidin-1-yl)penta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-2-methyl-2-(methylsulfonyl)butanamide (<b>9</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (37% yield) from <b>32</b> (0.150 g; 0.35 mmol) and <b>33c</b> (0.108 g; 0.40 mmol), followed by general procedure 4 (54% yield). Purification by prep-HPLC (basic) gave <b>9</b> as a white solid (0.033 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.95 (s, 1H), 9.19 (s, 1H), 7.59 (s, 1H), 6.28 (d, <i>J</i> = 1.1 Hz, 1H), 4.46–4.42 (br s, 2H), 3.49–3.44 (m, 4H), 3.07 (s, 3H), 2.72–2.66 (m, 2H), 2.61–2.57 (m, 1H), 2.23 (t, <i>J</i> = 9.5 Hz, 2H), 2.01–1.93 (m, 1H), 1.74–1.71 (m, 2H), 1.53 (s, 3H), 1.45–1.36 (m, 2H), 1.10 (t, <i>J</i> = 7.0 Hz, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 130.9, 117.9, 108.5, 105.9, 80.5, 74.0, 72.3, 69.8, 68.3, 65.4, 49.9 (2C), 47.3, 45.2, 39.5 (overlaid), 37.0, 34.7 (2C), 31.0, 13.3. MS (ESI, <i>m</i>/<i>z</i>): 477.0 [M + H<sup>+</sup>] for C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>6</sub>S; <i>t</i><sub><i>R</i></sub> = 0.49 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>6</sub>S 477.1808, found 477.1804; <i>t</i><sub><i>R</i></sub> = 0.79 min.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (2<i>R</i>)-<i>N</i>-Hydroxy-2-methyl-4-(6-((1-methylpiperidin-4-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-2-(methylsulfonyl)butanamide (<b>10</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 (30% yield) from <b>32</b> (0.100 g; 0.23 mmol) and <b>33n</b> (0.065 g; 0.26 mmol), followed by general procedure 2 (51% yield). Purification by prep-HPLC (basic) gave <b>10</b> as a white solid (0.016 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.91 (br s, 1H), 9.21 (br s, 1H), 7.57 (s, 1H), 6.27 (s, 1H), 4.44 (s, 2H), 3.59–3.33 (overlaid m, 4H), 3.07 (s, 3H), 2.66–2.50 (overlaid m, 3H), 2.15 (s, 3H), 2.12–2.02 (m, 1H), 2.01–1.91 (m, 1H), 1.86–1.75 (m, 2H), 1.64–1.53 (m, 2H), 1.53 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 130.9, 117.7, 108.8, 105.9, 87.6, 74.4, 71.6, 68.3, 66.2, 54.0 (2C), 46.6, 45.2, 39.5 (overlaid), 37.0, 31.4 (2C), 31.0, 27.0, 13.3. MS (ESI, <i>m</i>/<i>z</i>): 461.1 [M + H<sup>+</sup>] for C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>5</sub>S; <i>t</i><sub><i>R</i></sub> = 0.53 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>5</sub>S 461.1859, found 461.1862; <i>t</i><sub><i>R</i></sub> = 0.88 min.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (2<i>R</i>)-4-(6-((4-Fluoro-1-methylpiperidin-4-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>11</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (68% yield) from <b>32</b> (0.130 g; 0.307 mmol) and <b>33d</b> (0.074g; 0.338 mmol), followed by general procedure 2 (72% yield). Purification by prep-HPLC (basic) gave <b>11</b> as a yellowish solid (0.071 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.90 (br s, 1H), 9.19 (br s, 1H), 7.68 (s, 1H), 6.32 (d, <i>J</i> = 1.2 Hz, 1H), 4.45 (s, 2H), 3.55–3.46 (m, 1H), 3.45–3.36 (overlaid m, 1H), 3.06 (s, 3H), 2.66–2.55 (overlaid m, 1H), 2.48–2.29 (overlaid m, 4H), 2.19 (s, 3H), 2.04–1.93 (m, 5H), 1.53 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.3, 131.1, 118.7, 107.8, 106.0, 88.7 (d, <i>J</i> = 167 Hz, 1C), 81.0 (d, <i>J</i> = 30 Hz, 1C), 77.0 (d, <i>J</i> = 4 Hz, 1C), 72.7 (d, <i>J</i> = 6 Hz, 1C), 72.1, 68.3, 51.5 (2C), 45.9, 45.2, 39.5 (overlaid), 37.0, 36.8 (2C), 31.0, 13.3. MS (ESI, <i>m</i>/<i>z</i>): 479.1 [M + H<sup>+</sup>] for C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>5</sub>FS; <i>t</i><sub><i>R</i></sub> = 0.56 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>5</sub>FS 479.1764, found 479.1763; <i>t</i><sub><i>R</i></sub> = 0.91 min.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (2<i>R</i>)-<i>N</i>-Hydroxy-2-methyl-2-(methylsulfonyl)-4-(6-((1-(oxetan-3-yl)piperidin-4-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)butanamide (<b>12</b>)</h4><div class="NLM_p last">Prepared according to general procedure 5 (78% yield) from <b>32</b> (0.100 g; 0.23 mmol) and the <b>33o</b> (0.075 g; 0.26 mmol), followed by general procedure 2 (12% yield). Purification by prep-HPLC (basic) gave <b>12</b> as a white solid (0.011 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.96 (br s, 1H), 9.21 (br s, 1H), 7.57 (s, 1H), 6.27 (s, 1H), 4.52 (t, <i>J</i> = 6.5 Hz, 2H), 4.44 (s, 2H), 4.41 (t, <i>J</i> = 6.1 Hz, 2H), 3.55–3.45 (m, 1H), 3.45–3.34 (overlaid m, 2H), 3.08 (s, 3H), 2.70–2.54 (overlaid m, 2H), 2.49–2.43 (overlaid m, 1H), 2.09–1.90 (m, 4H), 1.89–1.77 (m, 2H), 1.65–1.53 (m, 2H), 1.54 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 163.8, 150.4, 130.9, 117.7, 108.7, 105.9, 87.5, 75.1 (2C), 74.3, 71.7, 68.3, 66.3, 59.1, 48.3 (2C), 45.2, 39.5 (overlaid), 37.0, 31.1 (2C), 31.0, 27.3, 13.3. MS (ESI, <i>m</i>/<i>z</i>): 503.1 [M + H<sup>+</sup>] for C<sub>24</sub>H<sub>30</sub>N<sub>4</sub>O<sub>6</sub>S; <i>t</i><sub><i>R</i></sub> = 0.53 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>24</sub>H<sub>30</sub>N<sub>4</sub>O<sub>6</sub>S 503.1964, found 503.1968; <i>t</i><sub><i>R</i></sub> = 0.88 min.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (2<i>R</i>)-<i>N</i>-Hydroxy-2-methyl-4-(6-((1-methylazetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-2-(methylsulfonyl)butanamide (<b>13</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 (64% yield) from <b>34</b> (2.37 g; 4.72 mmol) and a 37% aq formaldehyde solution <b>35a</b> (1.10 mL; 14.1 mmol) at rt for 30 min, followed by general procedure 2 (58% yield). Purification by prep-HPLC (basic) gave <b>13</b> as a white solid (1.30 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.94 (br s, 1H), 9.19 (br s, 1H), 7.56 (d, <i>J</i> = 1.0 Hz, 1H), 6.25 (d, <i>J</i> = 1.2 Hz, 1H), 4.43 (s, 2H), 3.53–3.45 (m, 3H), 3.43–3.36 (m, 1H), 3.35–3.30 (overlaid m, 1H), 3.06 (s, 3H), 2.99–2.94 (m, 2H), 2.63–2.55 (m, 1H), 2.18 (s, 3H), 2.00–1.93 (m, 1H), 1.52 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 130.9, 117.8, 108.6, 105.9, 85.1, 74.2, 72.6, 68.3, 67.0, 62.0 (2C), 46.0, 45.2, 39.5 (overlaid), 37.0, 31.0, 20.9, 13.3. MS (ESI, <i>m</i>/<i>z</i>): 433.0 [M + H<sup>+</sup>] for C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O<sub>5</sub>S; <i>t</i><sub><i>R</i></sub> = 0.50 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O<sub>5</sub>S 433.1546, found 433.1532; <i>t</i><sub><i>R</i></sub> = 0.80 min.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (2<i>R</i>)-4-(6-(Azetidin-3-ylbuta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>15</b>)</h4><div class="NLM_p last">Prepared according to general procedure 2 from <b>34</b> (0.15 g; 0.30 mmol). Purification by prep-HPLC (basic) gave <b>15</b> as a white solid (0.074 g; 59% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.99 (br s, 1H), 7.56 (s, 1H), 6.25 (d, <i>J</i> = 1.2 Hz, 1H), 4.43 (s, 2H), 3.63–3.45 (m, 6H), 3.42–3.35 (overlaid m, 1H), 3.05 (s, 3H), 2.63–2.54 (overlaid m, 1H), 2.00–1.92 (m, 1H), 1.49 (s, 3H), hydroxamic acid NH and OH missing. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.7, 150.4, 131.0, 117.8, 108.7, 105.9, 85.4, 74.2, 72.9, 68.3, 67.8, 52.9 (2C), 45.2, 39.5 (overlaid), 37.0, 31.0, 24.9, 13.4. MS (ESI, <i>m</i>/<i>z</i>): 419.0 [M + H<sup>+</sup>] for C<sub>19</sub>H<sub>22</sub>N<sub>4</sub>O<sub>5</sub>S; <i>t</i><sub><i>R</i></sub> = 0.49 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>19</sub>H<sub>22</sub>N<sub>4</sub>O<sub>5</sub>S 419.1389, found 419.1388; <i>t</i><sub><i>R</i></sub> = 0.79 min.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>R</i>)-<i>N</i>-Hydroxy-2-methyl-2-(methylsulfonyl)-4-(6-((1-(oxetan-3-yl)azetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H-</i>pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)butanamide (<b>16</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (84% yield) from <b>32</b> (0.400 g; 0.95 mmol) and <b>33e</b> (0.265 g; 1.23 mmol), followed by general procedure 2 (44% yield). Purification by prep-HPLC (basic) gave <b>16</b> as a yellowish solid (0.159 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.95 (br s, 1H), 9.19 (br s, 1H), 7.56 (d, <i>J</i> = 1.2 Hz, 1H), 6.26 (d, <i>J</i> = 1.2 Hz, 1H), 4.53 (t, <i>J</i> = 6.6 Hz, 2H), 4.43 (s, 2H), 4.31 (dd, <i>J</i> = 5.3, 6.4 Hz, 2H), 3.67 (m, 1H), 3.52 (overlaid t, <i>J</i> = 7.6 Hz, 2H), 3.49–3.30 (overlaid m, 3H), 3.14–3.10 (m, 2H), 3.05 (s, 3H), 2.63–2.57 (m, 1H), 2.01–1.93 (m, 1H), 1.51 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.9, 150.4, 131.0, 117.8, 108.6, 105.9, 84.9, 74.2, 74.1 (2C), 72.8, 68.4, 67.3, 58.6, 56.4 (2C), 45.2, 39.5 (overlaid), 37.0, 31.0, 21.1, 13.3. MS (ESI, <i>m</i>/<i>z</i>): 475.1 [M + H<sup>+</sup>] for C<sub>22</sub>H<sub>26</sub>N<sub>4</sub>O<sub>6</sub>S; <i>t</i><sub><i>R</i></sub> = 0.51 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>22</sub>H<sub>26</sub>N<sub>4</sub>O<sub>6</sub>S 475.1651, found 475.1648; <i>t</i><sub><i>R</i></sub> = 0.82 min.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (2<i>R</i>)-4-(6-((3-Fluoro-1-methylazetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>17</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (41% yield) from <b>32</b> (0.195 g; 0.46 mmol) and <b>33f</b> (0.111 g; 0.51 mmol), followed by general procedure 3 (49% yield) using a 37% aq formaldehyde solution (0.06 mL; 0.769 mmol) at rt for 2 h and general procedure 4 (38% yield). Purification by CC (DCM-MeOH) gave <b>17</b> as a yellowish solid (0.015 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.94 (s, 1H), 9.18 (s, 1H), 7.71–7.68 (m, 1H), 6.35–6.32 (m, 1H), 4.44 (s, 2H), 3.61–3.56 (m, 2H), 3.52–3.36 (m, 4H), 3.06 (s, 3H), 2.63–2.58 (m, 1H), 2.30 (s, 3H), 2.01–1.94 (m, 1H), 1.52 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.3, 131.1, 118.9, 107.6, 106.0, 83.6 (d, <i>J</i> = 201 Hz, 1C), 78.3 (d, <i>J</i> = 33 Hz, 1C), 77.9 (d, <i>J</i> = 3 Hz, 1C), 72.8 (d, <i>J</i> = 10 Hz, 1C), 72.5 (d, <i>J</i> = 6 Hz, 1C), 68.3, 67.6 (d, <i>J</i> = 23 Hz, 2C), 45.7, 45.2, 39.5 (overlaid), 37.0, 31.0, 13.4. MS (ESI, <i>m</i>/<i>z</i>): 451.0 [M + H<sup>+</sup>] for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>5</sub>FS; <i>t</i><sub><i>R</i></sub> = 0.51 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>5</sub>FS 451.1452, found 451.1452; <i>t</i><sub><i>R</i></sub> = 0.85 min.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (2<i>R</i>)-4-(6-((3-Fluoroazetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>18</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (24% yield) from <b>32</b> (0.126 g; 0.297 mmol) and <b>33f</b> (0.070 g; 0.326 mmol), followed by general procedure 2 (27% yield). Purification by prep-HPLC (basic) gave <b>18</b> as a yellowish solid (0.08 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 9.20 (br s, 1H), 7.69 (s, 1H), 6.33 (d, <i>J</i> = 1.3 Hz, 1H), 4.44 (s, 2H), 3.84–3.73 (m, 4H), 3.52–3.45 (m, 1H), 3.42–3.35 (overlaid m, 1H), 3.06 (s, 3H), 2.63–2.56 (m, 1H), 2.00–1.92 (m, 1H), 1.52 (s, 3H), hydroxamic acid NH and OH missing. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.7, 150.3, 131.1, 118.8, 107.6, 106.0, 87.8 (d, <i>J</i> = 204 Hz, 1C), 78.6 (d, <i>J</i> = 33 Hz, 1C), 77.9 (d, <i>J</i> = 3 Hz, 1C), 73.1 (d, <i>J</i> = 10 Hz, 1C), 72.6 (d, <i>J</i> = 6 Hz, 1C), 68.3, 58.9 (d, <i>J</i> = 25 Hz, 2C), 45.2, 39.5 (overlaid), 37.0, 30.9, 13.3. MS (ESI, <i>m</i>/<i>z</i>): 478.0 [M + MeCN + H<sup>+</sup>] for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>5</sub>FS; <i>t</i><sub><i>R</i></sub> = 0.52 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>5</sub>FS 437.1295, found 437.1294; <i>t</i><sub><i>R</i></sub> = 0.84 min.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (2<i>R</i>)-4-(6-((1-(2-Fluoroethyl)azetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>19</b>)</h4><div class="NLM_p last">Prepared according to general procedure 6 (45% yield) from <b>34</b> (0.600 g; 1.19 mmol) and 1-iodo-2-fluoroethane <b>36a</b> (0.120 mL; 1.44 mmol) at reflux for 4 h and adding an additional portion of 1-iodo-2-fluoroethane after 2 h, followed by general procedure 2 (72% yield). Purification by prep-HPLC (basic) gave <b>19</b> as a white solid (0.163 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.94 (br s, 1H), 9.18 (br s, 1H), 7.57 (s, 1H), 6.27 (d, <i>J</i> = 1.2 Hz, 1H), 4.49–4.39 (m, 3H), 4.33 (t, <i>J</i> = 4.8 Hz, 1H), 3.55 (t, <i>J</i> = 7.2 Hz, 2H), 3.52–3.45 (m, 1H), 3.44–3.36 (overlaid m, 2H), 3.08 (t, <i>J</i> = 6.3 Hz, 2H), 3.06 (s, 3H), 2.69 (t, <i>J</i> = 4.8 Hz, 1H), 2.63 (overlaid t, <i>J</i> = 4.4 Hz, 1H), 2.62–2.58 (overlaid m, 1H), 2.01–1.93 (m, 1H), 1.53 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 130.9, 117.8, 108.6, 105.9, 84.9, 83.1 (d, <i>J</i> = 164 Hz, 1C), 74.2, 72.7, 68.3, 67.2, 60.9 (2C), 58.4 (d, <i>J</i> = 4 Hz, 1C), 45.2, 39.5 (overlaid), 37.0, 31.0, 21.8, 13.4. MS (ESI, <i>m</i>/<i>z</i>): 465.1 [M + H<sup>+</sup>] for C<sub>21</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>FS; <i>t</i><sub><i>R</i></sub> = 0.52 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>21</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>FS 465.1608, found 465.1604; <i>t</i><sub><i>R</i></sub> = 0.83 min.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (2<i>R</i>)-4-(6-((1-(2,2-Difluoroethyl)azetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>20</b>)</h4><div class="NLM_p last">Prepared according to general procedure 6 (23% yield) from <b>34</b> (0.500 g; 0.995 mmol) and 2,2-difluoroethyl trifluoromethanesulfonate <b>36b</b> (0.203 mL; 1.49 mmol) at rt for 2 h, followed by general procedure 2 (73% yield). Purification by prep-HPLC (basic) gave <b>20</b> as a white solid (0.073 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.85 (br s, 1H), 9.17 (br s, 1H), 7.57 (d, <i>J</i> = 0.9 Hz, 1H), 6.26 (d, <i>J</i> = 1.2 Hz, 1H), 5.95 (tt, <i>J</i> = 55.2, 4.2 Hz, 1H), 4.43 (s, 2H), 3.59 (t, <i>J</i> = 7.4 Hz, 2H), 3.53–3.37 (m, 3H), 3.19 (t, <i>J</i> = 6.9 Hz, 2H), 3.06 (s, 3H), 2.81 (td, <i>J</i> = 16.2, 4.1 Hz, 2H), 2.62–2.55 (m, 1H), 2.01–1.91 (m, 1H), 1.52 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 131.0, 117.8, 116.2 (t, <i>J</i> = 239 Hz, 1C), 108.6, 105.9, 84.7, 74.1, 72.8, 68.3, 67.3, 61.3 (2C), 59.7 (t, <i>J</i> = 23 Hz, 1C), 45.2, 39.5 (overlaid), 37.0, 31.0, 22.0, 13.4. MS (ESI, <i>m</i>/<i>z</i>): 483.0 [M + H<sup>+</sup>] for C<sub>21</sub>H<sub>24</sub>N<sub>4</sub>O<sub>5</sub>F<sub>2</sub>S; <i>t</i><sub><i>R</i></sub> = 0.54 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>21</sub>H<sub>24</sub>N<sub>4</sub>O<sub>5</sub>F<sub>2</sub>S 483.1514, found 483.1510; <i>t</i><sub><i>R</i></sub> = 0.96 min.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (2<i>R</i>)-4-(6-((1-Ethylazetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>21</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 (45% yield) from <b>34</b> (0.511 g; 0.10 mmol) and a 5 M acetaldehyde solution in THF <b>35b</b> (0.62 mL; 3.1 mmol) at rt for 1 h, followed by general procedure 2 (58% yield). Purification by prep-HPLC (basic) gave <b>21</b> as a white solid (0.160 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.72 (br s, 1H), 9.20 (br s, 1H), 7.57 (s, 1H), 6.26 (s, 1H), 4.43 (s, 2H), 3.54–3.42 (m, 3H), 3.41–3.28 (overlaid m, 2H), 3.06 (s, 3H), 2.93 (t, <i>J</i> = 6.5 Hz, 2H), 2.65–2.55 (m, 1H), 2.35 (q, <i>J</i> = 7.1 Hz, 2H), 2.02–1.90 (m, 1H), 1.52 (s, 3H), 0.84 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 130.9, 117.8, 108.7, 105.9, 85.2, 74.2, 72.6, 68.3, 67.0, 59.9 (2C), 53.2, 45.2, 39.5 (overlaid), 37.0, 31.0, 21.0, 13.3, 12.6. MS (ESI, <i>m</i>/<i>z</i>): 447.0 [M + H<sup>+</sup>] for C<sub>21</sub>H<sub>26</sub>N<sub>4</sub>O<sub>5</sub>S; <i>t</i><sub><i>R</i></sub> = 0.52 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>21</sub>H<sub>26</sub>N<sub>4</sub>O<sub>5</sub>S 447.1702, found 447.1710; <i>t</i><sub><i>R</i></sub> = 0.84 min.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (2<i>R</i>)-<i>N</i>-Hydroxy-4-(6-((1-isopropylazetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-2-methyl-2-(methylsulfonyl)butanamide (<b>22</b>)</h4><div class="NLM_p last">Prepared according to general procedure 3 (60% yield) from <b>34</b> (0.100 g; 0.20 mmol) and acetone <b>35c</b> (0.045 mL; 0.60 mmol) at rt for 2 h, followed by general procedure 2 (63% yield). Purification by prep-HPLC (basic) gave <b>22</b> as a white solid (0.030 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.94 (br s, 1H), 9.20 (br s, 1H), 7.57 (s, 1H), 6.26 (d, <i>J</i> = 1.2 Hz, 1H), 4.43 (s, 2H), 3.54–3.23 (overlaid m, 5H), 3.06 (s, 3H), 2.99–2.90 (m, 2H), 2.63–57 (m, 1H), 2.29–2.21 (m, 1H), 2.01–1.93 (m, 1H), 1.53 (s, 3H), 0.83 (d, <i>J</i> = 6.2 Hz, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 130.9, 117.8, 108.7, 105.9, 85.3, 74.2, 72.6, 68.3, 66.9, 58.8 (2C), 58.1, 45.2, 39.5 (overlaid), 37.0, 31.0, 19.9, 19.8 (2C), 13.4. MS (ESI, <i>m</i>/<i>z</i>): 461.0 [M + H<sup>+</sup>] for C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>5</sub>S; <i>t</i><sub><i>R</i></sub> = 0.54 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>5</sub>S 461.1859, found 461.1863; <i>t</i><sub><i>R</i></sub> = 0.86 min.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (2<i>R</i>)-<i>N</i>-Hydroxy-4-(6-((1-(2-hydroxyethyl)azetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-2-methyl-2-(methylsulfonyl)butanamide (<b>23</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (80% yield) from <b>32</b> (3.50 g; 8.26 mmol) and <b>33q</b> (3.16 g; 9.92 mmol), followed by general procedure 7 (52% yield) and general procedure 2 (80% yield). Purification by prep-HPLC (basic) gave <b>23</b> as a white solid (1.19 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.94 (br s, 1H), 9.20 (br s, 1H), 7.57 (d, <i>J</i> = 1.0 Hz, 1H), 6.26 (d, <i>J</i> = 1.3 Hz, 1H), 4.43 (s, 2H), 4.42 (t, <i>J</i> = 5.5 Hz, 1H), 3.51 (t, <i>J</i> = 6.9 Hz, 2H), 3.54–3.45 (overlaid m, 1H), 3.42–3.31 (overlaid m, 4H), 3.06 (s, 3H), 3.03 (t, <i>J</i> = 6.9 Hz, 2H), 2.63–55 (m, 1H), 2.43 (t, <i>J</i> = 6.0 Hz, 2H), 2.00–1.93 (m, 1H), 1.53 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 130.9, 117.8, 108.7, 105.9, 85.2, 74.2, 72.7, 68.3, 67.1, 61.5, 60.9 (2C), 59.7, 45.2, 39.5 (overlaid), 37.0, 31.0, 21.8, 13.3. MS (ESI, <i>m</i>/<i>z</i>): 463.0 [M + H<sup>+</sup>] for C<sub>21</sub>H<sub>26</sub>N<sub>4</sub>O<sub>6</sub>S; <i>t</i><sub><i>R</i></sub> = 0.49 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>21</sub>H<sub>26</sub>N<sub>4</sub>O<sub>6</sub>S 463.1651, found 463.1649; <i>t</i><sub><i>R</i></sub> = 0.79 min.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>R</i>)-<i>N</i>-Hydroxy-4-(6-((1-(2-hydroxy-2-methylpropyl)azetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-2-methyl-2-(methylsulfonyl)butanamide (<b>24</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (93% yield) from <b>32</b> (0.300 g; 0.71 mmol) and <b>33g</b> (0.197 g; 0.85 mmol), followed by general procedure 2 (78% yield). Purification by prep-HPLC (basic) gave <b>24</b> as a yellowish solid (0.250 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.93 (br s, 1H), 9.18 (s, 1H), 7.57 (d, <i>J</i> = 0.8 Hz, 1H), 6.26 (d, <i>J</i> = 1.2 Hz, 1H), 4.44 (s, 2H), 4.06 (s, 1H), 3.57 (t, <i>J</i> = 7.4 Hz, 2H), 3.49 (m, 1H), 3.42–3.35 (overlaid m, 2H), 3.08–3.05 (m, 2H), 3.06 (overlaid s, 3H), 2.59 (m, 1H), 2.28 (s, 2H), 1.97 (m, 1H), 1.53 (s, 3H), 1.03 (s, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 130.9, 117.8, 108.7, 105.9, 85.2, 74.2, 72.7, 71.2, 70.0, 68.3, 67.1, 62.2 (2C), 45.2, 39.5 (overlaid), 37.0, 31.0, 28.4 (2C), 21.9, 13.3. MS (ESI, <i>m</i>/<i>z</i>): 491.1 [M + H<sup>+</sup>] for C<sub>23</sub>H<sub>30</sub>N<sub>4</sub>O<sub>6</sub>S; <i>t</i><sub><i>R</i></sub> = 0.53 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>23</sub>H<sub>30</sub>N<sub>4</sub>O<sub>6</sub>S 491.1964, found 491.1963; <i>t</i><sub><i>R</i></sub> = 0.85 min.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (2<i>R</i>)-4-(6-((1-Acetylazetidin-3-yl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>25</b>)</h4><div class="NLM_p last">To a solution of <b>34</b> (0.150 g; 0.298 mmol) in THF (10 mL) at rt were added DIPEA (0.319 mL; 1.87 mmol), HATU (0.170 mg; 0.448 mmol), and AcOH (0.025 mL, 0.448 mmol). The reaction mixture was stirred at rt for 18 h, poured into water (20 mL), and extracted with EtOAc (2 × 30 mL). The combined organic layers were washed with brine, filtered, and concentrated. Purification by CC (DCM–MeOH) gave a beige solid (0.131 g; 81% yield). It was subsequently reacted according to general procedure 2. Purification by prep-HPLC (basic) gave <b>25</b> as a white solid (0.063 g; 57% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.95 (br s, 1H), 8.90 (br s, 1H), 7.59 (s, 1H), 6.26 (s, 1H), 4.43 (s, 2H), 4.37 (t, <i>J</i> = 8.5 Hz, 1H), 4.13–4.07 (m, 2H), 3.76 (m, 1H), 3.66 (m, 1H), 3.48 (m, 1H), 3.38 (m, 1H), 3.05 (s, 3H), 2.56 (m, 1H), 1.92 (m, 1H), 1.75 (s, 3H), 1.47 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 170.4, 163.8, 150.4, 131.0, 118.0, 108.4, 105.9, 84.2, 73.9, 73.3, 68.3, 68.1, 56.0, 53.9, 45.2, 39.5 (overlaid), 37.0, 31.0, 19.2, 19.1, 13.4. MS (ESI, <i>m</i>/<i>z</i>): 461.0 [M + H<sup>+</sup>] for C<sub>21</sub>H<sub>24</sub>N<sub>4</sub>O<sub>6</sub>S; <i>t</i><sub><i>R</i></sub> = 0.67 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>21</sub>H<sub>24</sub>N<sub>4</sub>O<sub>6</sub>S 461.1495, found 461.1497; <i>t</i><sub><i>R</i></sub> = 1.05 min.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>R</i>)-<i>N</i>-Hydroxy-4-(6-(((<i>1R</i>,<i>2S</i>)-2-(hydroxymethyl)-2-methylcyclopropyl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H-</i>pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-2-methyl-2-(methylsulfonyl)butanamide (<b>27</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (70% yield) from <b>32</b> (0.100 g; 0.236 mmol) and <b>33h</b> (0.071 g; 0.307 mmol), however it was further stirred for 3 days at rt upon completion of coupling reaction in order for the acetate cleavage to be complete, followed by general procedure 4 (36% yield). Purification by prep-HPLC (acidic) followed by trituration in water (0.2 mL) gave <b>27</b> as a white solid (0.025 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.9 (br s, 1H), 9.18 (br s, 1H), 7.53 (s, 1H), 6.25 (d, <i>J</i> = 1.1 Hz, 1H), 4.74 (t, <i>J</i> = 5.8 Hz, 1H), 4.43 (s, 2H), 3.48 (m, 1H), 3.39 (m, 1H), 3.29 (dd, <i>J</i> = 5.9, 11.2 Hz, 1H), 3.21 (dd, <i>J</i> = 5.6, 11.2 Hz, 1H), 3.06 (s, 3H), 2.59 (m, 1H), 1.96 (m, 1H), 1.54 (overlaid m, 1H), 1.53 (br s, 3H), 1.17 (s, 3H), 1.03 (m, 1H), 0.61 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.9, 150.4, 130.9, 117.6, 109.0, 106.0, 86.2, 75.0, 70.0, 68.4, 66.6, 63.0, 45.2, 39.5 (overlaid), 37.0, 31.0, 27.2, 20.3, 17.6, 13.3, 10.8. MS (ESI, <i>m</i>/<i>z</i>): 448.0 [M + H<sup>+</sup>] for C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>6</sub>S; <i>t</i><sub><i>R</i></sub> = 0.68 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>6</sub>S 448.1542, found 448.1534; <i>t</i><sub><i>R</i></sub> = 1.13 min.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>R</i>)-4-(6-(((1<i>R</i>,2<i>R</i>)-2-Fluoro-2-(hydroxymethyl)cyclopropyl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H-</i>pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N-</i>hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>28</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (84% yield) from <b>32</b> (0.151 g; 0.356 mmol) and <b>33i</b> (0.116 g; 0.390 mmol), followed by general procedure 4 (86% yield). Purification by CC (heptane–EtOAc) gave <b>28</b> as a white solid (0.115 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.94 (s, 1 H), 9.18 (s, 1H), 7.57 (d, <i>J</i> = 0.9 Hz, 1H), 6.26 (d, <i>J</i> = 1.2 Hz, 1H), 5.23 (t, <i>J</i> = 6.1 Hz, 1H), 4.43 (s, 2H), 3.72–3.58 (m, 2H), 3.52–3.45 (m, 1H), 3.43–3.35 (m, 1H), 3.06 (s, 3H), 2.63–2.55 (m, 1H), 1.99–1.90 (m, 2H), 1.53 (s, 3H), 1.38–1.32 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.9, 150.4, 130.9, 117.9, 108.7, 106.0, 82.8 (d, <i>J</i> = 230 Hz), 82.1 (d, <i>J</i> = 5 Hz), 74.7, 70.8, 68.3, 63.8, 62.9 (d, <i>J</i> = 22 Hz), 45.2, 39.5 (overlaid), 37.0, 31.0, 18.4 (d, <i>J</i> = 11 Hz), 13.3, 10.8 (d, <i>J</i> = 11 Hz). MS (ESI, <i>m</i>/<i>z</i>): 452.0 [M + H<sup>+</sup>] for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>6</sub>FS; <i>t</i><sub><i>R</i></sub> = 0.65 min. Chiral LC (method 2); <i>t</i><sub><i>R</i></sub> = 3.33 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>6</sub>FS 452.1291, found 452.1290; <i>t</i><sub><i>R</i></sub> = 1.08 min.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>R</i>)-4-(6-(((1<i>S</i>,2<i>S</i>)-2-Fluoro-2-(hydroxymethyl)cyclopropyl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H-</i>pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N-</i>hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>29</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (76% yield) from <b>32</b> (0.150 g; 0.354 mmol) and <b>33j</b> (0.116 g; 0.390 mmol), followed by general procedure 4 (85% yield). Purification by CC (heptane–EtOAc) gave <b>29</b> as a white solid (0.103 g); alternatively, prepared according to general procedure 1 (96% yield) from <b>32</b> (0.90 g; 2.13 mmol) and <b>33k</b> (0.513 g; 2.66 mmol), followed by general procedure 4 (80% yield). Purification by CC (heptane–9:1 EtOAc/MeOH) gave <b>29</b> as a yellowish solid (0.729 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.94 (s, 1H), 9.18 (s, 1H), 7.56 (d, <i>J</i> = 0.9 Hz, 1H), 6.25 (d, <i>J</i> = 1.2 Hz, 1H), 5.23 (t, <i>J</i> = 6.1 Hz, 1H), 4.42 (s, 2H), 3.71–3.59 (m, 2H), 3.53–3.45 (m, 1H), 3.42–3.35 (m, 1H), 3.06 (s, 3H), 2.63–2.55 (m, 1H), 1.97–1.90 (m, 2H), 1.52 (s, 3H), 1.36–1.31 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.9, 150.4, 130.9, 117.9, 108.7, 106.0, 83.6, 82.8 (d, <i>J</i> = 230 Hz), 82.1 (d, <i>J</i> = 5 Hz), 74.6, 70.8, 68.3, 63.8, 62.9 (d, <i>J</i> = 22 Hz), 45.2, 39.5 (overlaid), 37.0, 31.0, 18.4 (d, <i>J</i> = 11 Hz), 13.3, 10.8 (d, <i>J</i> = 11 Hz). MS (ESI, <i>m</i>/<i>z</i>): 452.0 [M + H<sup>+</sup>] for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>6</sub>FS; <i>t</i><sub><i>R</i></sub> = 0.67 min. Chiral LC (method 2): <i>t</i><sub><i>R</i></sub> = 4.71 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>6</sub>FS 452.1292, found 452.1296; <i>t</i><sub><i>R</i></sub> = 1.08 min.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (2<i>R</i>)-4-(6-(((1<i>S</i>,2<i>S</i>)-2-((<i>R</i>)-1,2-Dihydroxyethyl)cyclopropyl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>30</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (79% yield) from <b>32</b> (2.25 g; 5.31 mmol) and <b>33l</b> (1.61 g; 7.83 mmol), followed by general procedure 4 (53% yield). Purification by prep-HPLC (acidic) followed by recrystallization (CH<sub>3</sub>CN/hexane) gave <b>30</b> as a white solid (1.03 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.94 (br s, 1H), 9.18 (br s, 1H), 7.52 (s, 1H), 6.23 (d, <i>J</i> = 1.1 Hz, 1H), 4.70 (d, <i>J</i> = 4.8 Hz, 1H), 4.61 (t, <i>J</i> = 5.6 Hz, 1H), 4.42 (s, 2H), 3.53–3.45 (m, 1H), 3.42–3.31 (overlaid m, 3H), 3.31–3.25 (m, 1H), 3.06 (s, 3H), 2.63–2.56 (m, 1H), 2.00–1.92 (m, 1H), 1.52 (s, 3H), 1.48–1.43 (m, 1H), 1.37–1.33 (m, 1H), 0.96–0.90 (m, 1H), 0.84–0.78 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.8, 150.4, 130.9, 117.6, 108.9, 106.0, 87.9, 74.9, 71.0, 70.1, 68.3, 65.9, 61.2, 45.2, 39.5 (overlaid), 37.0, 31.0, 26.0, 13.3, 12.1, 3.7. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>7</sub>S 464.1491, found 464.1488; <i>t</i><sub><i>R</i></sub> = 1.01 min.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (2<i>R</i>)-4-(6-(((1<i>R</i>,2<i>R</i>)-2-((<i>S</i>)-1,2-Dihydroxyethyl)cyclopropyl)buta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-<i>N</i>-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (<b>31</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 (54% yield) from <b>32</b> (0.250 g; 0.59 mmol) and <b>33m</b> (0.157 g; 0.766 mmol), followed by general procedure 4 (74% yield). Purification by prep-HPLC (acidic) gave <b>31</b> as a white solid (0.108 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.93 (br s, 1H), 9.18 (br s, 1H), 7.52 (s, 1H), 6.23 (d, <i>J</i> = 1.2 Hz, 1H), 4.69 (d, <i>J</i> = 5.1 Hz, 1H), 4.61 (t, <i>J</i> = 5.7 Hz, 1H), 4.42 (s, 2H), 3.53–3.44 (m, 1H), 3.41–3.36 (overlaid m, 3H), 3.31–3.25 (m, 1H), 3.06 (s, 3H), 2.63–2.55 (m, 1H), 1.99–1.92 (m, 1H), 1.52 (s, 3H), 1.49–1.43 (m, 1H), 1.37–1.31 (m, 1H), 0.96–0.90 (m, 1H), 0.84–0.78 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 163.9, 150.4, 130.9, 117.6, 109.0, 106.0, 87.9, 74.9, 71.0, 70.2, 68.4, 65.9, 61.2, 45.2, 39.5 (overlaid), 37.0, 31.0, 26.0, 13.3, 12.2, 3.7. MS (ESI, <i>m</i>/<i>z</i>): 464.0 [M + H<sup>+</sup>] for C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>7</sub>S; <i>t</i><sub><i>R</i></sub> = 0.48 min. LC-HRMS (ESI, <i>m</i>/<i>z</i>): [M + H<sup>+</sup>] calcd for C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>7</sub>S 464.1491, found 464.1488; <i>t</i><sub><i>R</i></sub> = 1.01 min.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (2<i>R</i>)-4-(6-(Azetidin-3-ylbuta-1,3-diyn-1-yl)-3-oxo-1<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-2(3<i>H</i>)-yl)-2-methyl-2-(methylsulfonyl)-<i>N</i>-((2<i>RS</i>)-(tetrahydro-2<i>H</i>-pyran-2-yl)oxy)butanamide (<b>34</b>)</h4><div class="NLM_p last">Prepared according to general procedure 1 from <b>32</b> (4.00 g; 9.45 mmol) and <b>33r</b> (3.24 g; 16.5 mmol). Purification by CC (DCM–MeOH) gave <b>34</b> as a yellow solid (3.06 g; 65% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ (1:1 mixture of diastereoisomers): 11.34 (m, 2 × 1H), 7.56 (s, 1H), 7.55 (s, 1H), 6.26 (m, 2 × 1H), 4.85 (s, 1H), 4.49 (m, 1H), 4.47–4.37 (m, 2 × 2H), 4.01 (m, 1H), 3.95 (m, 1H), 3.64–3.57 (m, 2 × 3H), 3.56–3.46 (m, 2 × 4H), 3.45–3.38 (m, 2 × 2H), 3.07 (s, 3H), 3.04 (s, 3H), 2.62 (m, 2 × 1H), 1.97 (m, 2 × 1H), 1.73–1.60 (m, 2 × 2H), 1.59–1.43 (overlaid m, 2 × 4H), 1.56 (s, 3H), 1.54 (s, 3H). MS (ESI, <i>m</i>/<i>z</i>): 503.2 [M + H<sup>+</sup>] for C<sub>24</sub>H<sub>30</sub>N<sub>4</sub>O<sub>6</sub>S; <i>t</i><sub><i>R</i></sub> = 0.59 min.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01605" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01605?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01605</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental details on preparation of recombinant Pae and Eco LpxC proteins; DSF measurement; MIC testing; log <i>D</i>, p<i>K</i><sub>a</sub>, and solubility determination; formulation trials; neutropenic murine thigh infection model; pharmacokinetics in the mouse and in the rat; MICs against PAO1 and PA2616 strains; graphical representation of in vivo efficacy and descriptive statistics; preparation of compounds <b>33a</b>–<b>r</b> and <b>14</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01605/suppl_file/jm9b01605_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01605/suppl_file/jm9b01605_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01605/suppl_file/jm9b01605_si_001.pdf">jm9b01605_si_001.pdf (1.87 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01605/suppl_file/jm9b01605_si_002.csv">jm9b01605_si_002.csv (4.23 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01605" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Panchaud</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7823-7639" title="Orcid link">http://orcid.org/0000-0001-7823-7639</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dbabb3b2b7b2ababbef5abbab5b8b3baaebf9bb2bfb4a9a8b2baf5b8b4b6"><span class="__cf_email__" data-cfemail="93e3fbfafffae3e3f6bde3f2fdf0fbf2e6f7d3faf7fce1e0faf2bdf0fcfe">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Philippe Surivet</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3505-2025" title="Orcid link">http://orcid.org/0000-0002-3505-2025</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Diethelm</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne-Catherine Blumstein</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Christophe Gauvin</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Loïc Jacob</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence Masse</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gaëlle Mathieu</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Azely Mirre</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Schmitt</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Enderlin-Paput</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland Lange</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmela Gnerre</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swen Seeland</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charlyse Herrmann</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans H. Locher</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span>; 
    <span>Present Address:
                        Hans H. Locher: Polyphor AG, Hegenheimermattweg 125, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Seiler</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Ritz</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georg Rueedi</span> - <span class="hlFld-Affiliation affiliation">Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Jonathan Delers, Mika Gaertner, Marina Dos Santos, Milène Walter, Nadia Ekambaran, Philippe Pfaff, François Le Goff, Marco Calderone, Maria Weiss, Susanne Schroeder, and Ulrike Babilonski are warmly thanked for the technical assistance they provided during the work described in the manuscript. We are grateful to the DMPK, Preformulation and Preclinical Galenics teams as well as to our colleagues from Process Research for their dedicated and continuous support. We thank the contract synthesis group at the Latvian Institute of Organic Synthesis led by Dr. Ronalds Zemribo for assistance in synthesis of building blocks. We thank Dr. Makda Fisseha for her helpful comments during the preparation of the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AMR</td><td class="NLM_def"><p class="first last">antimicrobial resistance</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the plasma concentration–time curve</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyl-diimidazole</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony forming unit</p></td></tr><tr><td class="NLM_term">Cipro</td><td class="NLM_def"><p class="first last">ciprofloxacin</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">total clearance</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">Cl<sub>u</sub></td><td class="NLM_def"><p class="first last">unbound clearance</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DSF</td><td class="NLM_def"><p class="first last">differential scanning fluorimetry</p></td></tr><tr><td class="NLM_term">Eco</td><td class="NLM_def"><p class="first last"><i>Escherichia coli</i></p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">ESBL</td><td class="NLM_def"><p class="first last">extended-spectrum β-lactamase</p></td></tr><tr><td class="NLM_term">Et<sub>2</sub>O</td><td class="NLM_def"><p class="first last">diethyl ether</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">GNB</td><td class="NLM_def"><p class="first last">Gram-negative bacteria</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">Imi</td><td class="NLM_def"><p class="first last">imipenem</p></td></tr><tr><td class="NLM_term">Kpn</td><td class="NLM_def"><p class="first last"><i>Klebsiella pneumoniae</i></p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimal inhibitory concentration</p></td></tr><tr><td class="NLM_term">nBuNH<sub>2</sub></td><td class="NLM_def"><p class="first last"><i>n</i>-butyl amine</p></td></tr><tr><td class="NLM_term">NH<sub>2</sub>OTHP</td><td class="NLM_def"><p class="first last"><i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine</p></td></tr><tr><td class="NLM_term">LpxC</td><td class="NLM_def"><p class="first last">UDP-3-<i>O</i>-((<i>R</i>)-3-hydroxymyristoyl)-<i>N</i>-acetylglucosamine deacetylase</p></td></tr><tr><td class="NLM_term">Pae</td><td class="NLM_def"><p class="first last"><i>Pseudomonas aeruginosa</i></p></td></tr><tr><td class="NLM_term">QR</td><td class="NLM_def"><p class="first last">quinolone-resistant</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">propylphosphonic anhydride</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">Tige</td><td class="NLM_def"><p class="first last">tigecycline</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span> <i>Antibiotic
Resistance Threats in the United States</i>; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>, <span class="NLM_year">2013</span>; <a href="https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf" class="extLink">https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf</a> (accessed May 5, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Antibiotic%0AResistance+Threats+in+the+United+States%3B+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2013%3B+https%3A%2F%2Fwww.cdc.gov%2Fdrugresistance%2Fpdf%2Far-threats-2013-508.pdf+%28accessed+May+5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotic%250AResistance%2520Threats%2520in%2520the%2520United%2520States%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, J.</span></span> <i>Tackling Drug-Resistant Infections Globally: Final Report and Recommendations</i>; <span class="NLM_publisher-name">Review on Antimicrobial Resistance</span>, <span class="NLM_year">2016</span>; <a href="http://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf" class="extLink">http://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf</a> (accessed May 5, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+O%E2%80%99Neill&title=Tackling+Drug-Resistant+Infections+Globally%3A+Final+Report+and+Recommendations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%26jtitle%3DTackling%2520Drug-Resistant%2520Infections%2520Globally%253A%2520Final%2520Report%2520and%2520Recommendations%26pub%3DReview%2520on%2520Antimicrobial%2520Resistance%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span> </span><span class="NLM_article-title">Surveillance of Antimicrobial
Resistancein Europe 2016</span>.  <i>Annual Report of
the European Antimicrobial Resistance
Surveillance Network (EARS-Net)</i>; <span class="NLM_publisher-name">European
Centre for Disease Prevention and Control</span>, <span class="NLM_publisher-loc">Stockholm</span>, <span class="NLM_year">2017</span>; <a href="https://www.ecdc.europa.eu/sites/portal/files/documents/AMR-surveillance-Europe-2016.pdf" class="extLink">https://www.ecdc.europa.eu/sites/portal/files/documents/AMR-surveillance-Europe-2016.pdf</a> (accessed May 5, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Surveillance+of+Antimicrobial%0AResistancein+Europe+2016.+Annual+Report+of%0Athe+European+Antimicrobial+Resistance%0ASurveillance+Network+%28EARS-Net%29%3B+European%0ACentre+for+Disease+Prevention+and+Control%2C+Stockholm%2C+2017%3B+https%3A%2F%2Fwww.ecdc.europa.eu%2Fsites%2Fportal%2Ffiles%2Fdocuments%2FAMR-surveillance-Europe-2016.pdf+%28accessed+May+5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26atitle%3DSurveillance%2520of%2520Antimicrobial%250AResistancein%2520Europe%25202016%26jtitle%3DAnnual%2520Report%2520of%250Athe%2520European%2520Antimicrobial%2520Resistance%250ASurveillance%2520Network%2520%2528EARS-Net%2529%26pub%3DEuropean%250ACentre%2520for%2520Disease%2520Prevention%2520and%2520Control%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span> <i>Global
Priority List of Antibiotic-Resistant Bacteria to Guide Research,
Discovery, and Development of New Antibiotics</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2017</span>; <a href="http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1" class="extLink">http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1</a> (accessed May 5, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global%0APriority+List+of+Antibiotic-Resistant+Bacteria+to+Guide+Research%2C%0ADiscovery%2C+and+Development+of+New+Antibiotics%3B+World+Health+Organization%3A+Geneva%2C+2017%3B+http%3A%2F%2Fwww.who.int%2Fmedicines%2Fpublications%2FWHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf%3Fua%3D1+%28accessed+May+5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%250APriority%2520List%2520of%2520Antibiotic-Resistant%2520Bacteria%2520to%2520Guide%2520Research%252C%250ADiscovery%252C%2520and%2520Development%2520of%2520New%2520Antibiotics%26pub%3DWorld%2520Health%2520Organization%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erwin, A. L.</span></span> <span> </span><span class="NLM_article-title">Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">a025304</span> <span class="refDoi"> DOI: 10.1101/cshperspect.a025304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1101%2Fcshperspect.a025304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=27235477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns1ymurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=A.+L.+Erwin&title=Antibacterial+Drug+Discovery+Targeting+the+Lipopolysaccharide+Biosynthetic+Enzyme+LpxC&doi=10.1101%2Fcshperspect.a025304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial drug discovery targeting the lipopolysaccharide biosynthetic enzyme LpxC</span></div><div class="casAuthors">Erwin, Alice L.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">a025304/1-a025304/15</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The enzyme LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase) is broadly conserved across Gram-neg. bacteria and is essential for synthesis of lipid A, the membrane anchor of the lipopolysaccharides (LPSs), which are a major component of the outer membrane in nearly all Gram-neg. bacteria.  LpxC has been the focus of targetdirected antibiotic discovery projects in numerous pharmaceutical and academic groups for more than 20 years.  Despite intense effort, no LpxC inhibitor has been approved for therapeutic use, and only one has yet reached human studies.  This article will summarize the history of LpxC as a drug target and the parallel history of research on LpxC biol.  Both academic and industrial researchers have used LpxC inhibitors as tool compds., leading to increased understanding of the differing mechanisms for regulation of LPS synthesis in Escherichia coli and Pseudomonas aeruginosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-AZMwFme-97Vg90H21EOLACvtfcHk0lhhPznVpu6IqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns1ymurc%253D&md5=a8ca24f54a9aaad079b94a41cfab62a4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025304%26sid%3Dliteratum%253Aachs%26aulast%3DErwin%26aufirst%3DA.%2BL.%26atitle%3DAntibacterial%2520Drug%2520Discovery%2520Targeting%2520the%2520Lipopolysaccharide%2520Biosynthetic%2520Enzyme%2520LpxC%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2016%26volume%3D6%26doi%3D10.1101%2Fcshperspect.a025304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span> <span> </span><span class="NLM_article-title">Recent Process in the Inhibitors of UDP-3-<i>O</i>-(<i>R</i>-3-Hydroxyacyl)-<i>N</i>-Acetylglucosamine Deacetylase (LpxC) against Gram-Negative Bacteria</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.2174/1389557516666161013120253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.2174%2F1389557516666161013120253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=27739357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=310-323&author=F.+Liuauthor=S.+Ma&title=Recent+Process+in+the+Inhibitors+of+UDP-3-O-%28R-3-Hydroxyacyl%29-N-Acetylglucosamine+Deacetylase+%28LpxC%29+against+Gram-Negative+Bacteria&doi=10.2174%2F1389557516666161013120253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Process in the Inhibitors of UDP-3-O-(R-3-hydroxyacyl)-Nacetylglucosamine Deacetylase (LpxC) Against Gram-Negative Bacteria</span></div><div class="casAuthors">Liu, Fang; Ma, Shutao</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">310-323</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Infections caused by pathogenic bacteria are a major health concern throughout the world.  There is a great need to develop novel antibacterial agents with new mechanisms of action.  Lipopolysaccharides (LPS) are the main component of the outer membrane of Gram-neg. bacteria, serving as a permeability barrier, which protects the bacteria from many antibiotics.  The UDP-3-O-(R-3- hydroxyacyl)-N-acetylglucosamine deacetylase (LpxC), a Zn2+-dependent enzyme, catalyzes the first irreversible step of the biosynthesis of lipid A, the hydrophobic membrane anchor of LPS being essential for cell viability.  Addnl., it shares no sequence or structural homol. with any mammalian proteins.  Therefore, it may become a novel target for the new drugs against Gram-neg. bacteria.  Thus, research on LpxC inhibitors as new antibacterial agents has become an attractive field in the development of the novel antibiotic therapy of Gram-neg. bacteria.  In this review, we will summarize the recent progress in the structure and catalytic mechanism of LpxC and the research and development of LpxC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCCo2nX8eUNLVg90H21EOLACvtfcHk0lhhPznVpu6IqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ansb8%253D&md5=b3b5e46355981c9fe6a68f197de57841</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1389557516666161013120253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557516666161013120253%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DS.%26atitle%3DRecent%2520Process%2520in%2520the%2520Inhibitors%2520of%2520UDP-3-O-%2528R-3-Hydroxyacyl%2529-N-Acetylglucosamine%2520Deacetylase%2520%2528LpxC%2529%2520against%2520Gram-Negative%2520Bacteria%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2018%26volume%3D18%26spage%3D310%26epage%3D323%26doi%3D10.2174%2F1389557516666161013120253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalinin, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holl, R.</span></span> <span> </span><span class="NLM_article-title">Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor Design</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2379</span>– <span class="NLM_lpage">2430</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413135835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.2174%2F1568026616666160413135835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=27072691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOgs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2379-2430&author=D.+V.+Kalininauthor=R.+Holl&title=Insights+into+the+Zinc-Dependent+Deacetylase+LpxC%3A+Biochemical+Properties+and+Inhibitor+Design&doi=10.2174%2F1568026616666160413135835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor Design</span></div><div class="casAuthors">Kalinin, Dmitrii V.; Holl, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2379-2430</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The bacterial enzyme UDP-3-O-[(R)-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase (LpxC), catalyzing the first committed step of lipid A biosynthesis, represents a promising target in the development of novel antibiotics against Gram-neg. bacteria.  Structure, catalytic reaction mechanism and regulation of the Zn2+-dependent metalloamidase have been intensively investigated.  The enzyme is required for growth and viability of Gram-neg. bacteria, displays no sequence homol. with any mammalian protein, but is highly conserved in Gram-neg. bacteria, thus permitting the development of Gram-neg. selective antibacterial agents with limited off-target effects.  Several small mol. LpxC inhibitors have been developed, like the substrate analog TU-514 (12a), the aryloxazoline L-161,240 (13w), the sulfonamide BB-78485 (23a), the N-aroyl-L-threonine deriv. CHIR-090 (24a), the sulfone-contg. pyridone LpxC-3 (43e), and the uridine-based inhibitor 1-68A (47a), displaying diverse inhibitory and antibacterial activities.  Most of these compds. share a Zn2+-binding hydroxamate moiety attached to a structural element addressing the hydrophobic tunnel or the UDP binding site.  The butadiynyl deriv. ACHN-975 (28) is the first LpxC inhibitor entering clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod_JborvvzXbVg90H21EOLACvtfcHk0lgouckeQXijiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOgs7fE&md5=82abc89ee4dab91b95bbb9dabb23f0b3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413135835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413135835%26sid%3Dliteratum%253Aachs%26aulast%3DKalinin%26aufirst%3DD.%2BV.%26aulast%3DHoll%26aufirst%3DR.%26atitle%3DInsights%2520into%2520the%2520Zinc-Dependent%2520Deacetylase%2520LpxC%253A%2520Biochemical%2520Properties%2520and%2520Inhibitor%2520Design%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2379%26epage%3D2430%26doi%3D10.2174%2F1568026616666160413135835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raetz, C. R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fierke, C. A.</span></span> <span> </span><span class="NLM_article-title">UDP-3-<i>O</i>-(<i>R</i>-3-Hydroxymyristoyl)-<i>N</i>-Acetylglucosamine Deacetylase of <i>Escherichia Coli</i> Is a Zinc Metalloenzyme</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1902</span>– <span class="NLM_lpage">1911</span>, <span class="refDoi"> DOI: 10.1021/bi982339s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi982339s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1902-1911&author=J.+E.+Jackmanauthor=C.+R.+H.+Raetzauthor=C.+A.+Fierke&title=UDP-3-O-%28R-3-Hydroxymyristoyl%29-N-Acetylglucosamine+Deacetylase+of+Escherichia+Coli+Is+a+Zinc+Metalloenzyme&doi=10.1021%2Fbi982339s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">UDP-3-O-(R-3-Hydroxymyristoyl)-N-acetylglucosamine Deacetylase of Escherichia coli Is a Zinc Metalloenzyme</span></div><div class="casAuthors">Jackman, Jane E.; Raetz, Christian R. H.; Fierke, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1902-1911</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enzyme UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc deacetylase (LpxC) catalyzes the committed step in the biosynthesis of lipid A and is therefore a potential antibiotic target.  Inhibition of this enzyme by hydroxamate compds. suggested the presence of a metal ion cofactor.  We have investigated the substrate specificity and metal dependence of the deacetylase using spectroscopic and kinetic analyses.  Comparison of the steady-state kinetic parameters for the physiol. substrate UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc and an alternative substrate, UDP-GlcNAc, demonstrates that the ester-linked R-3-hydroxymyristoyl chain increases kcat/KM (5 × 106)-fold.  Metal-chelating reagents, such as dipicolinic acid (DPA) and EDTA, completely inhibit LpxC activity, implicating an essential metal ion.  Plasma emission spectroscopy and colorimetric assays directly demonstrate that purified LpxC contains bound Zn2+.  This Zn2+ can be removed by incubation with DPA, causing a decrease in the LpxC activity that can be restored by subsequent addn. of Zn2+.  However, high concns. of Zn2+ also inhibit LpxC.  Addn. of Co2+, Ni2+, or Mn2+ to apo-LpxC also activates the enzyme to varying degrees while no addnl. activity is obsd. upon the addn. of Cd2+, Ca2+, Mg2+, or Cu2+.  This is consistent with the profile of metals that substitute for catalytic zinc ions in metalloproteinases.  Co2+ ions stimulate LpxC activity maximally at a stoichiometry of 1:1.  These data demonstrate that E. coli LpxC is a metalloenzyme that requires bound Zn2+ for optimal activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoETi4nWY-kpLVg90H21EOLACvtfcHk0lgouckeQXijiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFymsw%253D%253D&md5=43e4ad7d68cbbd04a202c898c7bb667a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbi982339s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi982339s%26sid%3Dliteratum%253Aachs%26aulast%3DJackman%26aufirst%3DJ.%2BE.%26aulast%3DRaetz%26aufirst%3DC.%2BR.%2BH.%26aulast%3DFierke%26aufirst%3DC.%2BA.%26atitle%3DUDP-3-O-%2528R-3-Hydroxymyristoyl%2529-N-Acetylglucosamine%2520Deacetylase%2520of%2520Escherichia%2520Coli%2520Is%2520a%2520Zinc%2520Metalloenzyme%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D1902%26epage%3D1911%26doi%3D10.1021%2Fbi982339s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silhavy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S.</span></span> <span> </span><span class="NLM_article-title">The Bacterial Cell Envelope</span>. <i>Cold Spring Harbor Perspect. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">a000414</span> <span class="refDoi"> DOI: 10.1101/cshperspect.a000414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1101%2Fcshperspect.a000414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=20452953" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&author=T.+J.+Silhavyauthor=D.+Kahneauthor=S.+Walker&title=The+Bacterial+Cell+Envelope&doi=10.1101%2Fcshperspect.a000414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a000414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a000414%26sid%3Dliteratum%253Aachs%26aulast%3DSilhavy%26aufirst%3DT.%2BJ.%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DWalker%26aufirst%3DS.%26atitle%3DThe%2520Bacterial%2520Cell%2520Envelope%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2010%26volume%3D2%26doi%3D10.1101%2Fcshperspect.a000414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Surivet, J.-P.</span>; <span class="NLM_string-name">Panchaud, P.</span>; <span class="NLM_string-name">Specklin, J.-L.</span>; <span class="NLM_string-name">Diethelm, S.</span>; <span class="NLM_string-name">Blumstein, A.-C.</span>; <span class="NLM_string-name">Gauvin, J.-C.</span>; <span class="NLM_string-name">Jacob, L.</span>; <span class="NLM_string-name">Masse, F.</span>; <span class="NLM_string-name">Mathieu, G.</span>; <span class="NLM_string-name">Mirre, A.</span>; <span class="NLM_string-name">Schmitt, C.</span>; <span class="NLM_string-name">Lange, R.</span>; <span class="NLM_string-name">Tidten-Luksch, N.</span>; <span class="NLM_string-name">Gnerre, C.</span>; <span class="NLM_string-name">Seeland, S.</span>; <span class="NLM_string-name">Herrmann, C.</span>; <span class="NLM_string-name">Seiler, P.</span>; <span class="NLM_string-name">Enderlin-Paput, M.</span>; <span class="NLM_string-name">Mac Sweeney, A.</span>; <span class="NLM_string-name">Wicki, M.</span>; <span class="NLM_string-name">Hubschwerlen, C.</span>; <span class="NLM_string-name">Ritz, D.</span>; <span class="NLM_string-name">Rueedi, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel Inhibitors of LpxC Displaying Potent in Vitro Activity against Gram-Negative Bacteria</span>,  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01604</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01604" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=J.-P.+Surivet&author=P.+Panchaud&author=J.-L.+Specklin&author=S.+Diethelm&author=A.-C.+Blumstein&author=J.-C.+Gauvin&author=L.+Jacob&author=F.+Masse&author=G.+Mathieu&author=A.+Mirre&author=C.+Schmitt&author=R.+Lange&author=N.+Tidten-Luksch&author=C.+Gnerre&author=S.+Seeland&author=C.+Herrmann&author=P.+Seiler&author=M.+Enderlin-Paput&author=A.+Mac+Sweeney&author=M.+Wicki&author=C.+Hubschwerlen&author=D.+Ritz&author=G.+Rueedi&title=Discovery+of+Novel+Inhibitors+of+LpxC+Displaying+Potent+in+Vitro+Activity+against+Gram-Negative+Bacteria&doi=10.1021%2Facs.jmedchem.9b01604"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01604%26sid%3Dliteratum%253Aachs%26aulast%3DSurivet%26aufirst%3DJ.-P.%26atitle%3DDiscovery%2520of%2520Novel%2520Inhibitors%2520of%2520LpxC%2520Displaying%2520Potent%2520in%2520Vitro%2520Activity%2520against%2520Gram-Negative%2520Bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26doi%3D10.1021%2Facs.jmedchem.9b01604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramite, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcari, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barham, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collantes, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desbonnet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engtrakul, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huband, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knafels, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plummer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishka, D. G.</span></span> <span> </span><span class="NLM_article-title">Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">914</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.1021/jm2014748</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014748" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=914-923&author=M.+F.+Brownauthor=U.+Reillyauthor=J.+A.+Abramiteauthor=J.+T.+Arcariauthor=R.+Oliverauthor=R.+A.+Barhamauthor=Y.+Cheauthor=J.+M.+Chenauthor=E.+M.+Collantesauthor=S.+W.+Chungauthor=C.+Desbonnetauthor=J.+Dotyauthor=M.+Doroskiauthor=J.+J.+Engtrakulauthor=T.+M.+Harrisauthor=M.+Hubandauthor=J.+D.+Knafelsauthor=K.+L.+Leachauthor=S.+Liuauthor=A.+Marfatauthor=A.+Marraauthor=E.+McElroyauthor=M.+Melnickauthor=C.+A.+Menardauthor=J.+I.+Montgomeryauthor=L.+Mullinsauthor=M.+C.+Noeauthor=J.+O%E2%80%99Donnellauthor=J.+Penzienauthor=M.+S.+Plummerauthor=L.+M.+Priceauthor=V.+Shanmugasundaramauthor=C.+Thomaauthor=D.+P.+Uccelloauthor=J.+S.+Warmusauthor=D.+G.+Wishka&title=Potent+Inhibitors+of+LpxC+for+the+Treatment+of+Gram-Negative+Infections&doi=10.1021%2Fjm2014748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections</span></div><div class="casAuthors">Brown, Matthew F.; Reilly, Usa; Abramite, Joseph A.; Arcari, Joel T.; Oliver, Robert; Barham, Rose A.; Che, Ye; Chen, Jinshan Michael; Collantes, Elizabeth M.; Chung, Seung Won; Desbonnet, Charlene; Doty, Jonathan; Doroski, Matthew; Engtrakul, Juntyma J.; Harris, Thomas M.; Huband, Michael; Knafels, John D.; Leach, Karen L.; Liu, Shenping; Marfat, Anthony; Marra, Andrea; McElroy, Eric; Melnick, Michael; Menard, Carol A.; Montgomery, Justin I.; Mullins, Lisa; Noe, Mark. C.; O'Donnell, John; Penzien, Joseph; Plummer, Mark S.; Price, Loren M.; Shanmugasundaram, Veerabahu; Thoma, Christy; Uccello, Daniel P.; Warmus, Joseph S.; Wishka, Donn G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">914-923</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, the synthesis and SAR as well as selectivity, pharmacokinetic, and infection model data for representative analogs of a novel series of potent antibacterial LpxC inhibitors represented by hydroxamic acid I, is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpizPNDLsgyIbVg90H21EOLACvtfcHk0lhVg9B4WoD9Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7rE&md5=fda4af453d09a4baa25cac35f69f5ac3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm2014748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014748%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DReilly%26aufirst%3DU.%26aulast%3DAbramite%26aufirst%3DJ.%2BA.%26aulast%3DArcari%26aufirst%3DJ.%2BT.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DBarham%26aufirst%3DR.%2BA.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DCollantes%26aufirst%3DE.%2BM.%26aulast%3DChung%26aufirst%3DS.%2BW.%26aulast%3DDesbonnet%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%26aulast%3DDoroski%26aufirst%3DM.%26aulast%3DEngtrakul%26aufirst%3DJ.%2BJ.%26aulast%3DHarris%26aufirst%3DT.%2BM.%26aulast%3DHuband%26aufirst%3DM.%26aulast%3DKnafels%26aufirst%3DJ.%2BD.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMarfat%26aufirst%3DA.%26aulast%3DMarra%26aufirst%3DA.%26aulast%3DMcElroy%26aufirst%3DE.%26aulast%3DMelnick%26aufirst%3DM.%26aulast%3DMenard%26aufirst%3DC.%2BA.%26aulast%3DMontgomery%26aufirst%3DJ.%2BI.%26aulast%3DMullins%26aufirst%3DL.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%26aulast%3DPenzien%26aufirst%3DJ.%26aulast%3DPlummer%26aufirst%3DM.%2BS.%26aulast%3DPrice%26aufirst%3DL.%2BM.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DThoma%26aufirst%3DC.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26atitle%3DPotent%2520Inhibitors%2520of%2520LpxC%2520for%2520the%2520Treatment%2520of%2520Gram-Negative%2520Infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D914%26epage%3D923%26doi%3D10.1021%2Fjm2014748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramite, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collantes, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desbonnet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engtrakul, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huband, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knafels, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitton-Fry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plummer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaras, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishka, D. G.</span></span> <span> </span><span class="NLM_article-title">Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1662</span>– <span class="NLM_lpage">1670</span>, <span class="refDoi"> DOI: 10.1021/jm2014875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1662-1670&author=J.+I.+Montgomeryauthor=M.+F.+Brownauthor=U.+Reillyauthor=L.+M.+Priceauthor=J.+A.+Abramiteauthor=J.+Arcariauthor=R.+Barhamauthor=Y.+Cheauthor=J.+M.+Chenauthor=S.+W.+Chungauthor=E.+M.+Collantesauthor=C.+Desbonnetauthor=M.+Doroskiauthor=J.+Dotyauthor=J.+J.+Engtrakulauthor=T.+M.+Harrisauthor=M.+Hubandauthor=J.+D.+Knafelsauthor=K.+L.+Leachauthor=S.+Liuauthor=A.+Marfatauthor=L.+McAllisterauthor=E.+McElroyauthor=C.+A.+Menardauthor=M.+Mitton-Fryauthor=L.+Mullinsauthor=M.+C.+Noeauthor=J.+O%E2%80%99Donnellauthor=R.+Oliverauthor=J.+Penzienauthor=M.+Plummerauthor=V.+Shanmugasundaramauthor=C.+Thomaauthor=A.+P.+Tomarasauthor=D.+P.+Uccelloauthor=A.+Vazauthor=D.+G.+Wishka&title=Pyridone+Methylsulfone+Hydroxamate+LpxC+Inhibitors+for+the+Treatment+of+Serious+Gram-Negative+Infections&doi=10.1021%2Fjm2014875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections</span></div><div class="casAuthors">Montgomery, Justin I.; Brown, Matthew F.; Reilly, Usa; Price, Loren M.; Abramite, Joseph A.; Arcari, Joel; Barham, Rose; Che, Ye; Chen, Jinshan Michael; Chung, Seung Won; Collantes, Elizabeth M.; Desbonnet, Charlene; Doroski, Matthew; Doty, Jonathan; Engtrakul, Juntyma J.; Harris, Thomas M.; Huband, Michael; Knafels, John D.; Leach, Karen L.; Liu, Shenping; Marfat, Anthony; McAllister, Laura; McElroy, Eric; Menard, Carol A.; Mitton-Fry, Mark; Mullins, Lisa; Noe, Mark C.; O'Donnell, John; Oliver, Robert; Penzien, Joseph; Plummer, Mark; Shanmugasundaram, Veerabahu; Thoma, Christy; Tomaras, Andrew P.; Uccello, Daniel P.; Vaz, Alfin; Wishka, Donn G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1662-1670</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and biol. activity of a new series of LpxC inhibitors represented by pyridone methylsulfone hydroxamate 2a (I) is presented.  Members of this series have improved soly. and free fraction when compared to compds. in the previously described biphenyl methylsulfone hydroxamate series, and they maintain superior Gram-neg. antibacterial activity to comparator agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgNGd-bEXEabVg90H21EOLACvtfcHk0lh6YmjtXA07XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVyjtw%253D%253D&md5=f2410aae177b2fa24d8da72942b95564</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm2014875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014875%26sid%3Dliteratum%253Aachs%26aulast%3DMontgomery%26aufirst%3DJ.%2BI.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DReilly%26aufirst%3DU.%26aulast%3DPrice%26aufirst%3DL.%2BM.%26aulast%3DAbramite%26aufirst%3DJ.%2BA.%26aulast%3DArcari%26aufirst%3DJ.%26aulast%3DBarham%26aufirst%3DR.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DChung%26aufirst%3DS.%2BW.%26aulast%3DCollantes%26aufirst%3DE.%2BM.%26aulast%3DDesbonnet%26aufirst%3DC.%26aulast%3DDoroski%26aufirst%3DM.%26aulast%3DDoty%26aufirst%3DJ.%26aulast%3DEngtrakul%26aufirst%3DJ.%2BJ.%26aulast%3DHarris%26aufirst%3DT.%2BM.%26aulast%3DHuband%26aufirst%3DM.%26aulast%3DKnafels%26aufirst%3DJ.%2BD.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMarfat%26aufirst%3DA.%26aulast%3DMcAllister%26aufirst%3DL.%26aulast%3DMcElroy%26aufirst%3DE.%26aulast%3DMenard%26aufirst%3DC.%2BA.%26aulast%3DMitton-Fry%26aufirst%3DM.%26aulast%3DMullins%26aufirst%3DL.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DPenzien%26aufirst%3DJ.%26aulast%3DPlummer%26aufirst%3DM.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DThoma%26aufirst%3DC.%26aulast%3DTomaras%26aufirst%3DA.%2BP.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DVaz%26aufirst%3DA.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26atitle%3DPyridone%2520Methylsulfone%2520Hydroxamate%2520LpxC%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Serious%2520Gram-Negative%2520Infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1662%26epage%3D1670%26doi%3D10.1021%2Fjm2014875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomaras, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carifa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desbonnet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidem, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. P.</span></span> <span> </span><span class="NLM_article-title">LpxC Inhibitors as New Antibacterial Agents and Tools for Studying Regulation of Lipid A Biosynthesis in Gram-Negative Pathogens</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e01551-14</span> <span class="refDoi"> DOI: 10.1128/mBio.01551-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1128%2FmBio.01551-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=25271285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=A.+P.+Tomarasauthor=C.+J.+McPhersonauthor=M.+Kuhnauthor=A.+Carifaauthor=L.+Mullinsauthor=D.+Georgeauthor=C.+Desbonnetauthor=T.+M.+Eidemauthor=J.+I.+Montgomeryauthor=M.+F.+Brownauthor=U.+Reillyauthor=A.+A.+Millerauthor=J.+P.+O%E2%80%99Donnell&title=LpxC+Inhibitors+as+New+Antibacterial+Agents+and+Tools+for+Studying+Regulation+of+Lipid+A+Biosynthesis+in+Gram-Negative+Pathogens&doi=10.1128%2FmBio.01551-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FmBio.01551-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01551-14%26sid%3Dliteratum%253Aachs%26aulast%3DTomaras%26aufirst%3DA.%2BP.%26aulast%3DMcPherson%26aufirst%3DC.%2BJ.%26aulast%3DKuhn%26aufirst%3DM.%26aulast%3DCarifa%26aufirst%3DA.%26aulast%3DMullins%26aufirst%3DL.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DDesbonnet%26aufirst%3DC.%26aulast%3DEidem%26aufirst%3DT.%2BM.%26aulast%3DMontgomery%26aufirst%3DJ.%2BI.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DReilly%26aufirst%3DU.%26aulast%3DMiller%26aufirst%3DA.%2BA.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DLpxC%2520Inhibitors%2520as%2520New%2520Antibacterial%2520Agents%2520and%2520Tools%2520for%2520Studying%2520Regulation%2520of%2520Lipid%2520A%2520Biosynthesis%2520in%2520Gram-Negative%2520Pathogens%26jtitle%3DmBio%26date%3D2014%26volume%3D5%26doi%3D10.1128%2FmBio.01551-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gad, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spainhour, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemake, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stricker-Krongrad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downing, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seals, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eagle, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polhamus, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J.</span></span> <span> </span><span class="NLM_article-title">Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species with Notes on Methods to Improve Utility</span>. <i>Int. J. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1177/1091581815622442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1177%2F1091581815622442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=26755718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A280%3ADC%252BC28rpt1emtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=95-178&author=S.+C.+Gadauthor=C.+B.+Spainhourauthor=C.+Shoemakeauthor=D.+R.+Pallmanauthor=A.+Stricker-Krongradauthor=P.+A.+Downingauthor=R.+E.+Sealsauthor=L.+A.+Eagleauthor=K.+Polhamusauthor=J.+Daly&title=Tolerable+Levels+of+Nonclinical+Vehicles+and+Formulations+Used+in+Studies+by+Multiple+Routes+in+Multiple+Species+with+Notes+on+Methods+to+Improve+Utility&doi=10.1177%2F1091581815622442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species With Notes on Methods to Improve Utility</span></div><div class="casAuthors">Gad Shayne Cox; Eagle Leslie Anne; Spainhour Charles B; Pallman Danielle R Stackhouse; Shoemake Catherine; Stricker-Krongrad Alain; Downing Philip A; Seals Richard E; Polhamus Kara; Daly Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">International journal of toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-178</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Formulation of nonclinical evaluations is a challenge, with the fundamental need to achieve multiples of the clinical exposure complicated by differences in species and routes of administration-specific tolerances, depending on concentrations, volumes, dosing regimen, duration of each administration, and study duration.  Current practice to approach these differences is based on individual experience and scattered literature with no comprehensive data source (the most notable exception being our 2006 publication on this same subject).  Lack of formulation tolerance data results in excessive animal use, unplanned delays in the evaluation and development of drugs, and vehicle-dependent results.  A consulting firm, a chemical company, and 4 contract research organizations conducted a rigorous data mining operation of vehicle data from studies dating from 1991 to 2015, enhancing the data from this author's 2006 publication (3 of the six 2015 contributors were also 2006 contributors).  Additional data were found in the published literature.  The results identified 108 single-component vehicles (and 305 combination formulations) used in more than 1,040 studies across multiple species (dog, primate, rat, mouse, rabbit, guinea pig, minipig, pig, chick embryo, and cat) by multiple routes for a wide range of study durations.  The tabulated data include maximum tolerated use levels by species, route, duration of study, dose-limiting toxicity where reported, review of the available literature on each vehicle, guidance on syringe selection, volume and pH limits by route with basic guidance on nonclinical formulation development, and guidance on factors to be considered in nonclinical route selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGnyl3PdyDRJPq5LRczm8ffW6udTcc2eay4XcNcEYlhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rpt1emtw%253D%253D&md5=797586f4df5a222f3f78da7495ec1396</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1177%2F1091581815622442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1091581815622442%26sid%3Dliteratum%253Aachs%26aulast%3DGad%26aufirst%3DS.%2BC.%26aulast%3DSpainhour%26aufirst%3DC.%2BB.%26aulast%3DShoemake%26aufirst%3DC.%26aulast%3DPallman%26aufirst%3DD.%2BR.%26aulast%3DStricker-Krongrad%26aufirst%3DA.%26aulast%3DDowning%26aufirst%3DP.%2BA.%26aulast%3DSeals%26aufirst%3DR.%2BE.%26aulast%3DEagle%26aufirst%3DL.%2BA.%26aulast%3DPolhamus%26aufirst%3DK.%26aulast%3DDaly%26aufirst%3DJ.%26atitle%3DTolerable%2520Levels%2520of%2520Nonclinical%2520Vehicles%2520and%2520Formulations%2520Used%2520in%2520Studies%2520by%2520Multiple%2520Routes%2520in%2520Multiple%2520Species%2520with%2520Notes%2520on%2520Methods%2520to%2520Improve%2520Utility%26jtitle%3DInt.%2520J.%2520Toxicol.%26date%3D2016%26volume%3D35%26spage%3D95%26epage%3D178%26doi%3D10.1177%2F1091581815622442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neervannan, S.</span></span> <span> </span><span class="NLM_article-title">Preclinical Formulations for Discovery and Toxicology: Physicochemical Challenges</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1517/17425255.2.5.715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1517%2F17425255.2.5.715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=17014391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtValtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=715-731&author=S.+Neervannan&title=Preclinical+Formulations+for+Discovery+and+Toxicology%3A+Physicochemical+Challenges&doi=10.1517%2F17425255.2.5.715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical formulations for discovery and toxicology: physicochemical challenges</span></div><div class="casAuthors">Neervannan, Seshadri</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">715-731</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Formulations play a key role in assessing the biol. properties of a mol. during drug discovery.  Maximising exposure is the primary objective in early animal experimentation, so that the pharmacokinetics, pharmacodynamics and toxicol. signals can be put into context with the biol. response to specific targets.  Consistency in the exposure is also a key aspect, and effective formulation and drug delivery strategies are important to achieve this.  Diversity in the physiol. between various animal species, routes of administration and limitations posed by specific pharmacol. models make formulation development that much more challenging.  Poor physicochem. properties of compds. in the early stages need to be kept under consideration while screening for formulation vehicles.  This review captures the various challenges posed at different stages of drug discovery for formulation of a compd. to dose in animals.  Approaches to formulations for various routes of administration are discussed.  Limitations posed by the goals for various animal studies such as early efficacy studies, pharmacokinetic studies and toxicol. studies are identified and some strategies are proposed.  Physicochem. characterizations that are needed to select formulation vehicles as well as to identify potential issues are suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnqg8ruyksJ7Vg90H21EOLACvtfcHk0limkVAuRE3v1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtValtbvE&md5=4946da3cdb43f2394dd9c5e24c7dc5ba</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F17425255.2.5.715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2.5.715%26sid%3Dliteratum%253Aachs%26aulast%3DNeervannan%26aufirst%3DS.%26atitle%3DPreclinical%2520Formulations%2520for%2520Discovery%2520and%2520Toxicology%253A%2520Physicochemical%2520Challenges%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2006%26volume%3D2%26spage%3D715%26epage%3D731%26doi%3D10.1517%2F17425255.2.5.715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of Fluorine in Medicinal Chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+Fluorine+in+Medicinal+Chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0limkVAuRE3v1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520Fluorine%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wuitschik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreira, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrilla, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span> <span> </span><span class="NLM_article-title">Oxetanes in Drug Discovery: Structural and Synthetic Insights</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3227</span>– <span class="NLM_lpage">3246</span>, <span class="refDoi"> DOI: 10.1021/jm9018788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9018788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3227-3246&author=G.+Wuitschikauthor=E.+M.+Carreiraauthor=B.+Wagnerauthor=H.+Fischerauthor=I.+Parrillaauthor=F.+Schulerauthor=M.+Rogers-Evansauthor=K.+Muller&title=Oxetanes+in+Drug+Discovery%3A+Structural+and+Synthetic+Insights&doi=10.1021%2Fjm9018788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Oxetanes in Drug Discovery: Structural and Synthetic Insights</span></div><div class="casAuthors">Wuitschik, Georg; Carreira, Erick M.; Wagner, Bjorn; Fischer, Holger; Parrilla, Isabelle; Schuler, Franz; Rogers-Evans, Mark; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3227-3246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of oxetanes as replacements for gem-di-Me or carbonyl groups and their effects on the aq. soly., lipophilicity, metabolic stability, and conformation for various compds. are studied; methods for the prepn. of a variety of substituted oxetanes are given.  The magnitude of changes in properties and in metabolic stability with oxetane substitution depends on the structural context; for example, substitution of a gem-di-Me group with an oxetane, aq. soly. may increase by a factor of 4 to more than 4000 while reducing the rate of metabolic degrdn. in most cases.  Incorporation of an oxetane into an aliph. chain increases in some cases the preference for synclinal conformations rather than antiplanar conformations of the chain.  Spirocyclic oxetanes such as an oxazaspiroheptane resemble commonly used fragments in drug discovery, such as morpholines, and in some cases increase aq. soly. more effectively than morpholines.  An improved chemoselective oxidn. of 3-oxetanol to 3-oxetanone is disclosed; olefination of 3-oxetanone by a variety of methods yields alkylideneoxetanes I [R = (EtO)2P(:O), OHC, O2N, EtO2C, NC, PhO2S, MeCO, 1-(4-chlorophenyl)-1-cyclobutanecarbonyl].  I (R = EtO2C, OHC, O2N) undergo addn. reactions with nucleophiles such as amines, carbonyl compds., and arylboronic acids to give oxetanes such as II.  The crystal structures of a variety of oxetanes are detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYbJqJGrlPJrVg90H21EOLACvtfcHk0liUgOIfC8kQtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D&md5=e95742d38e933c2fb0d76d638ccc773c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm9018788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9018788%26sid%3Dliteratum%253Aachs%26aulast%3DWuitschik%26aufirst%3DG.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DParrilla%26aufirst%3DI.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DOxetanes%2520in%2520Drug%2520Discovery%253A%2520Structural%2520and%2520Synthetic%2520Insights%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3227%26epage%3D3246%26doi%3D10.1021%2Fjm9018788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahne, D.</span></span> <span> </span><span class="NLM_article-title">On the Essentiality of Lipopolysaccharide to Gram-Negative Bacteria</span>. <i>Curr. Opin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1016/j.mib.2013.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1016%2Fj.mib.2013.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=24148302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=779-785&author=G.+Zhangauthor=T.+C.+Meredithauthor=D.+Kahne&title=On+the+Essentiality+of+Lipopolysaccharide+to+Gram-Negative+Bacteria&doi=10.1016%2Fj.mib.2013.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">On the essentiality of lipopolysaccharide to Gram-negative bacteria</span></div><div class="casAuthors">Zhang, Ge; Meredith, Timothy C.; Kahne, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">779-785</span>CODEN:
                <span class="NLM_cas:coden">COMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1369-5274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Lipopolysaccharide is a highly acylated saccharolipid located on the outer leaflet of the outer membrane of Gram-neg. bacteria.  Lipopolysaccharide is crit. to maintaining the barrier function preventing the passive diffusion of hydrophobic solutes such as antibiotics and detergents into the cell.  Lipopolysaccharide has been considered an essential component for outer membrane biogenesis and cell viability based on pioneering studies in the model Gram-neg. organisms Escherichia coli and Salmonella.  With the isolation of lipopolysaccharide-null mutants in Neisseria meningitidis, Moraxella catarrhalis, and most recently in Acinetobacter baumannii, it has become increasingly apparent that lipopolysaccharide is not an essential outer membrane building block in all organisms.  We suggest the accumulation of toxic intermediates, misassembly of essential outer membrane porins, and outer membrane stress response pathways that are activated by mislocalized lipopolysaccharide may collectively contribute to the obsd. strain-dependent essentiality of lipopolysaccharide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKMIl8joRZXbVg90H21EOLACvtfcHk0liUgOIfC8kQtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqtLfE&md5=3dfe6c82b93a0f6744da022718ca1c5d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.mib.2013.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mib.2013.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DMeredith%26aufirst%3DT.%2BC.%26aulast%3DKahne%26aufirst%3DD.%26atitle%3DOn%2520the%2520Essentiality%2520of%2520Lipopolysaccharide%2520to%2520Gram-Negative%2520Bacteria%26jtitle%3DCurr.%2520Opin.%2520Microbiol.%26date%3D2013%26volume%3D16%26spage%3D779%26epage%3D785%26doi%3D10.1016%2Fj.mib.2013.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span> <span> </span><span class="NLM_article-title">Bulky Trialkylsilyl Acetylenes in the Cadiot-Chodkiewicz Cross-Coupling Reaction</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">6841</span>– <span class="NLM_lpage">6844</span>, <span class="refDoi"> DOI: 10.1021/jo025745x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo025745x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsFSqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=6841-6844&author=J.+P.+Marinoauthor=H.+N.+Nguyen&title=Bulky+Trialkylsilyl+Acetylenes+in+the+Cadiot-Chodkiewicz+Cross-Coupling+Reaction&doi=10.1021%2Fjo025745x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Bulky Trialkylsilyl Acetylenes in the Cadiot-Chodkiewicz Cross-Coupling Reaction</span></div><div class="casAuthors">Marino, Joseph P.; Nguyen, Hanh Nho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6841-6844</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bulky trialkylsilyl-protected alkynes such as triethylsilyl (TES), tert-butyldimethylsilyl (TBS), and triisopropylsilyl (TIPS) acetylenes underwent the Cadiot-Chodkiewicz cross-coupling reaction with different bromoalkynes to form a variety of synthetically useful unsym. diynes in good yields.  The diyne alc. TESC≡CC≡CCH2OH was transformed regio- and stereoselectively into enynes by hydrotelluration, carbometalation, and redn. reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVGUUQOAdK2LVg90H21EOLACvtfcHk0liUgOIfC8kQtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsFSqu74%253D&md5=a74f5a735db24d2e4ad34929b6637c61</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo025745x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025745x%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26atitle%3DBulky%2520Trialkylsilyl%2520Acetylenes%2520in%2520the%2520Cadiot-Chodkiewicz%2520Cross-Coupling%2520Reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D6841%26epage%3D6844%26doi%3D10.1021%2Fjo025745x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapoux, G.</span>; <span class="NLM_string-name">Gauvin, J.-C.</span>; <span class="NLM_string-name">Panchaud, P.</span>; <span class="NLM_string-name">Specklin, J.-L.</span>; <span class="NLM_string-name">Surivet, J.-P.</span>; <span class="NLM_string-name">Schmitt, C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Dihydropyrrolo[1,2-<i>c</i>]imidazol-3-one Derivatives Useful as Antibacterial Agents</span>. PCT International Patent WO <span class="NLM_patent">WO 2015132228 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=G.+Chapoux&author=J.-C.+Gauvin&author=P.+Panchaud&author=J.-L.+Specklin&author=J.-P.+Surivet&author=C.+Schmitt&title=Preparation+of+Dihydropyrrolo%5B1%2C2-c%5Dimidazol-3-one+Derivatives+Useful+as+Antibacterial+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChapoux%26aufirst%3DG.%26atitle%3DPreparation%2520of%2520Dihydropyrrolo%255B1%252C2-c%255Dimidazol-3-one%2520Derivatives%2520Useful%2520as%2520Antibacterial%2520Agents%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blumstein, A.-C.</span>; <span class="NLM_string-name">Chapoux, G.</span>; <span class="NLM_string-name">Jacob, L.</span>; <span class="NLM_string-name">Masse, F.</span>; <span class="NLM_string-name">Mirre, A.</span>; <span class="NLM_string-name">Panchaud, P.</span>; <span class="NLM_string-name">Schmitt, C.</span>; <span class="NLM_string-name">Surivet, J.-P.</span>; <span class="NLM_string-name">Specklin, J.-L.</span></span> <span> </span><span class="NLM_article-title">Substituted 1,2-Dihydro-3<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-3-one Antibacterial Compounds</span>. PCT International Patent WO <span class="NLM_patent">WO 2017037221 A1</span>, 2017.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Blumstein%2C+A.-C.%3B+Chapoux%2C+G.%3B+Jacob%2C+L.%3B+Masse%2C+F.%3B+Mirre%2C+A.%3B+Panchaud%2C+P.%3B+Schmitt%2C+C.%3B+Surivet%2C+J.-P.%3B+Specklin%2C+J.-L.+Substituted+1%2C2-Dihydro-3H-pyrrolo%5B1%2C2-c%5Dimidazol-3-one+Antibacterial+Compounds.+PCT+International+Patent+WO+WO+2017037221+A1%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlumstein%26aufirst%3DA.-C.%26atitle%3DSubstituted%25201%252C2-Dihydro-3H-pyrrolo%255B1%252C2-c%255Dimidazol-3-one%2520Antibacterial%2520Compounds" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaninger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karge, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abele, S.</span></span> <span> </span><span class="NLM_article-title">Scalable Process for the Production of a Highly Energetic Bromoacetylene Building Block</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.8b00223</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.8b00223" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWjtLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=1409-1418&author=P.+Kohlerauthor=M.+Schwaningerauthor=A.+Stutzauthor=R.+Kargeauthor=S.+Abele&title=Scalable+Process+for+the+Production+of+a+Highly+Energetic+Bromoacetylene+Building+Block&doi=10.1021%2Facs.oprd.8b00223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Scalable Process for the Production of a Highly Energetic Bromoacetylene Building Block</span></div><div class="casAuthors">Kohler, Philipp; Schwaninger, Mischa; Stutz, Alfred; Karge, Reinhard; Abele, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1409-1418</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-(Bromoethynyl)azetidine is a highly energetic building block (decompn. energy up to -1800 J g-1) that was required in multikilogram quantities for the prodn. of an API.  The development of a four-step, fully telescoped, scalable sequence for its synthesis is described, along with a detailed safety study of the corresponding hydrochloride salt in order to det. the potential explosive properties and transport classification.  A screen of counterions identified the (+)-camphorsulfonic acid salt as the most suitable form for mitigation of the energetic properties, as judged by differential scanning calorimetry (onset 182 °C, energy -876 J g-1).  This case study demonstrates how a daunting chem. structure can be "tamed" by chem. process development, tuning of mol. properties, and thorough safety investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogkk3IgDa0tbVg90H21EOLACvtfcHk0liuEpkYf62D8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWjtLjF&md5=6ba3c82a50658ce2961378d485286b2d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.8b00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.8b00223%26sid%3Dliteratum%253Aachs%26aulast%3DKohler%26aufirst%3DP.%26aulast%3DSchwaninger%26aufirst%3DM.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DKarge%26aufirst%3DR.%26aulast%3DAbele%26aufirst%3DS.%26atitle%3DScalable%2520Process%2520for%2520the%2520Production%2520of%2520a%2520Highly%2520Energetic%2520Bromoacetylene%2520Building%2520Block%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2018%26volume%3D22%26spage%3D1409%26epage%3D1418%26doi%3D10.1021%2Facs.oprd.8b00223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Charles S. Jolly, Emma Kochanowski, Cayden J. Dodd, Savannah J. Post, Harrison M. Hill, <span class="NLM_string-name hlFld-ContribAuthor">Mark Turlington</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective Synthesis of Terminal Bromo-Substituted Propargylamines via Generation of Lithium Bromoacetylide and Addition to Chiral N-tert-Butanesulfinyl Aldimines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (3)
                                     , 2667-2681. <a href="https://doi.org/10.1021/acs.joc.0c02697" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02697%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDiastereoselective%252BSynthesis%252Bof%252BTerminal%252BBromo-Substituted%252BPropargylamines%252Bvia%252BGeneration%252Bof%252BLithium%252BBromoacetylide%252Band%252BAddition%252Bto%252BChiral%252BN-tert-Butanesulfinyl%252BAldimines%26aulast%3DJolly%26aufirst%3DCharles%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D11112020%26date%3D15012021%26volume%3D86%26issue%3D3%26spage%3D2667%26epage%3D2681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jean-Philippe Surivet, Philippe Panchaud, Jean-Luc Specklin, Stefan Diethelm, Anne-Catherine Blumstein, Jean-Christophe Gauvin, Loïc Jacob, Florence Masse, Gaëlle Mathieu, Azely Mirre, Christine Schmitt, Roland Lange, Naomi Tidten-Luksch, Carmela Gnerre, Swen Seeland, Charlyse Herrmann, Peter Seiler, Michel Enderlin-Paput, Aengus Mac Sweeney, Micha Wicki, Christian Hubschwerlen, Daniel Ritz, <span class="NLM_string-name hlFld-ContribAuthor">Georg Rueedi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Inhibitors of LpxC Displaying Potent in Vitro Activity against Gram-Negative Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (1)
                                     , 66-87. <a href="https://doi.org/10.1021/acs.jmedchem.9b01604" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01604%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BInhibitors%252Bof%252BLpxC%252BDisplaying%252BPotent%252Bin%252BVitro%252BActivity%252Bagainst%252BGram-Negative%252BBacteria%26aulast%3DSurivet%26aufirst%3DJean-Philippe%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D27092019%26date%3D24122019%26date%3D05122019%26volume%3D63%26issue%3D1%26spage%3D66%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Jeffries</span>, <span class="hlFld-ContribAuthor ">Zhong  Wang</span>, <span class="hlFld-ContribAuthor ">Robert I  Troup</span>, <span class="hlFld-ContribAuthor ">Anaïs  Goupille</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Le Questel</span>, <span class="hlFld-ContribAuthor ">Charlene  Fallan</span>, <span class="hlFld-ContribAuthor ">James S  Scott</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Chiarparin</span>, <span class="hlFld-ContribAuthor ">Jérôme  Graton</span>, <span class="hlFld-ContribAuthor ">Bruno  Linclau</span>. </span><span class="cited-content_cbyCitation_article-title">Lipophilicity trends upon fluorination of isopropyl, cyclopropyl and 3-oxetanyl groups. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>16 </em>, 2141-2150. <a href="https://doi.org/10.3762/bjoc.16.182" title="DOI URL">https://doi.org/10.3762/bjoc.16.182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.16.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.16.182%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLipophilicity%252Btrends%252Bupon%252Bfluorination%252Bof%252Bisopropyl%25252C%252Bcyclopropyl%252Band%252B3-oxetanyl%252Bgroups%26aulast%3DJeffries%26aufirst%3DBenjamin%26date%3D2020%26date%3D2020%26volume%3D16%26spage%3D2141%26epage%3D2150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01605&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Methylsulfone hydroxamate LpxC inhibitors reported by Idorsia (<b>1</b>–<b>3</b>) and Pfizer (<b>4</b>,<b>5</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01605&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Derivatives Using Cadiot–Chodkiewicz and Sonogashira Coupling<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01605&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CuCl, NH<sub>2</sub>OH·HCl, <i>n</i>-BuNH<sub>2</sub>, 0 °C–rt, 2 h; (b) HCl, 9:1 MeOH/H<sub>2</sub>O, rt, 1 h; (c) PPTS, EtOH, 80 °C, 2 h; (d) CuI, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Et<sub>3</sub>N, THF, 40 °C, 1 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Derivatives <b>7</b>, <b>17</b>, and <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01605&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CuCl, NH<sub>2</sub>OH·HCl, <i>n</i>-BuNH<sub>2</sub>, 0 °C–rt, 2 h; (b) HCHO, NaBH(OAc)<sub>3</sub>, DCM, rt, 1–16 h; (c) HCl, 9:1 MeOH/H<sub>2</sub>O, rt, 1 h; (d) PPTS, EtOH, 80 °C, 2 h; (e) TBAF, THF, rt, 3 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/medium/jm9b01605_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Azetidine Derivatives from Intermediate <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01605/20200106/images/large/jm9b01605_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01605&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CuCl, NH<sub>2</sub>OH·HCl, <i>n</i>-BuNH<sub>2</sub>, 0 °C–rt, 2 h; (b) HCl, 9:1 MeOH/H<sub>2</sub>O, rt, 1 h; (c) NaBH(OAc)<sub>3</sub>, DCM, rt, 1–2 h; (d) DIPEA, THF, rt–reflux, 2–4 h; (e) AcOH, HATU, DIPEA, THF, rt, 18 h.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span> <i>Antibiotic
Resistance Threats in the United States</i>; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>, <span class="NLM_year">2013</span>; <a href="https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf" class="extLink">https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf</a> (accessed May 5, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Antibiotic%0AResistance+Threats+in+the+United+States%3B+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2013%3B+https%3A%2F%2Fwww.cdc.gov%2Fdrugresistance%2Fpdf%2Far-threats-2013-508.pdf+%28accessed+May+5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotic%250AResistance%2520Threats%2520in%2520the%2520United%2520States%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, J.</span></span> <i>Tackling Drug-Resistant Infections Globally: Final Report and Recommendations</i>; <span class="NLM_publisher-name">Review on Antimicrobial Resistance</span>, <span class="NLM_year">2016</span>; <a href="http://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf" class="extLink">http://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf</a> (accessed May 5, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+O%E2%80%99Neill&title=Tackling+Drug-Resistant+Infections+Globally%3A+Final+Report+and+Recommendations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%26jtitle%3DTackling%2520Drug-Resistant%2520Infections%2520Globally%253A%2520Final%2520Report%2520and%2520Recommendations%26pub%3DReview%2520on%2520Antimicrobial%2520Resistance%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span> </span><span class="NLM_article-title">Surveillance of Antimicrobial
Resistancein Europe 2016</span>.  <i>Annual Report of
the European Antimicrobial Resistance
Surveillance Network (EARS-Net)</i>; <span class="NLM_publisher-name">European
Centre for Disease Prevention and Control</span>, <span class="NLM_publisher-loc">Stockholm</span>, <span class="NLM_year">2017</span>; <a href="https://www.ecdc.europa.eu/sites/portal/files/documents/AMR-surveillance-Europe-2016.pdf" class="extLink">https://www.ecdc.europa.eu/sites/portal/files/documents/AMR-surveillance-Europe-2016.pdf</a> (accessed May 5, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Surveillance+of+Antimicrobial%0AResistancein+Europe+2016.+Annual+Report+of%0Athe+European+Antimicrobial+Resistance%0ASurveillance+Network+%28EARS-Net%29%3B+European%0ACentre+for+Disease+Prevention+and+Control%2C+Stockholm%2C+2017%3B+https%3A%2F%2Fwww.ecdc.europa.eu%2Fsites%2Fportal%2Ffiles%2Fdocuments%2FAMR-surveillance-Europe-2016.pdf+%28accessed+May+5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26atitle%3DSurveillance%2520of%2520Antimicrobial%250AResistancein%2520Europe%25202016%26jtitle%3DAnnual%2520Report%2520of%250Athe%2520European%2520Antimicrobial%2520Resistance%250ASurveillance%2520Network%2520%2528EARS-Net%2529%26pub%3DEuropean%250ACentre%2520for%2520Disease%2520Prevention%2520and%2520Control%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span> <i>Global
Priority List of Antibiotic-Resistant Bacteria to Guide Research,
Discovery, and Development of New Antibiotics</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2017</span>; <a href="http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1" class="extLink">http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1</a> (accessed May 5, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global%0APriority+List+of+Antibiotic-Resistant+Bacteria+to+Guide+Research%2C%0ADiscovery%2C+and+Development+of+New+Antibiotics%3B+World+Health+Organization%3A+Geneva%2C+2017%3B+http%3A%2F%2Fwww.who.int%2Fmedicines%2Fpublications%2FWHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf%3Fua%3D1+%28accessed+May+5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%250APriority%2520List%2520of%2520Antibiotic-Resistant%2520Bacteria%2520to%2520Guide%2520Research%252C%250ADiscovery%252C%2520and%2520Development%2520of%2520New%2520Antibiotics%26pub%3DWorld%2520Health%2520Organization%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erwin, A. L.</span></span> <span> </span><span class="NLM_article-title">Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">a025304</span> <span class="refDoi"> DOI: 10.1101/cshperspect.a025304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1101%2Fcshperspect.a025304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=27235477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns1ymurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=A.+L.+Erwin&title=Antibacterial+Drug+Discovery+Targeting+the+Lipopolysaccharide+Biosynthetic+Enzyme+LpxC&doi=10.1101%2Fcshperspect.a025304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial drug discovery targeting the lipopolysaccharide biosynthetic enzyme LpxC</span></div><div class="casAuthors">Erwin, Alice L.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">a025304/1-a025304/15</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The enzyme LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase) is broadly conserved across Gram-neg. bacteria and is essential for synthesis of lipid A, the membrane anchor of the lipopolysaccharides (LPSs), which are a major component of the outer membrane in nearly all Gram-neg. bacteria.  LpxC has been the focus of targetdirected antibiotic discovery projects in numerous pharmaceutical and academic groups for more than 20 years.  Despite intense effort, no LpxC inhibitor has been approved for therapeutic use, and only one has yet reached human studies.  This article will summarize the history of LpxC as a drug target and the parallel history of research on LpxC biol.  Both academic and industrial researchers have used LpxC inhibitors as tool compds., leading to increased understanding of the differing mechanisms for regulation of LPS synthesis in Escherichia coli and Pseudomonas aeruginosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-AZMwFme-97Vg90H21EOLACvtfcHk0lj7a2BBSwOb8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns1ymurc%253D&md5=a8ca24f54a9aaad079b94a41cfab62a4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025304%26sid%3Dliteratum%253Aachs%26aulast%3DErwin%26aufirst%3DA.%2BL.%26atitle%3DAntibacterial%2520Drug%2520Discovery%2520Targeting%2520the%2520Lipopolysaccharide%2520Biosynthetic%2520Enzyme%2520LpxC%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2016%26volume%3D6%26doi%3D10.1101%2Fcshperspect.a025304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span> <span> </span><span class="NLM_article-title">Recent Process in the Inhibitors of UDP-3-<i>O</i>-(<i>R</i>-3-Hydroxyacyl)-<i>N</i>-Acetylglucosamine Deacetylase (LpxC) against Gram-Negative Bacteria</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.2174/1389557516666161013120253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.2174%2F1389557516666161013120253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=27739357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=310-323&author=F.+Liuauthor=S.+Ma&title=Recent+Process+in+the+Inhibitors+of+UDP-3-O-%28R-3-Hydroxyacyl%29-N-Acetylglucosamine+Deacetylase+%28LpxC%29+against+Gram-Negative+Bacteria&doi=10.2174%2F1389557516666161013120253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Process in the Inhibitors of UDP-3-O-(R-3-hydroxyacyl)-Nacetylglucosamine Deacetylase (LpxC) Against Gram-Negative Bacteria</span></div><div class="casAuthors">Liu, Fang; Ma, Shutao</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">310-323</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Infections caused by pathogenic bacteria are a major health concern throughout the world.  There is a great need to develop novel antibacterial agents with new mechanisms of action.  Lipopolysaccharides (LPS) are the main component of the outer membrane of Gram-neg. bacteria, serving as a permeability barrier, which protects the bacteria from many antibiotics.  The UDP-3-O-(R-3- hydroxyacyl)-N-acetylglucosamine deacetylase (LpxC), a Zn2+-dependent enzyme, catalyzes the first irreversible step of the biosynthesis of lipid A, the hydrophobic membrane anchor of LPS being essential for cell viability.  Addnl., it shares no sequence or structural homol. with any mammalian proteins.  Therefore, it may become a novel target for the new drugs against Gram-neg. bacteria.  Thus, research on LpxC inhibitors as new antibacterial agents has become an attractive field in the development of the novel antibiotic therapy of Gram-neg. bacteria.  In this review, we will summarize the recent progress in the structure and catalytic mechanism of LpxC and the research and development of LpxC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCCo2nX8eUNLVg90H21EOLACvtfcHk0lhx5RvGN9Ip0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ansb8%253D&md5=b3b5e46355981c9fe6a68f197de57841</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1389557516666161013120253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557516666161013120253%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DS.%26atitle%3DRecent%2520Process%2520in%2520the%2520Inhibitors%2520of%2520UDP-3-O-%2528R-3-Hydroxyacyl%2529-N-Acetylglucosamine%2520Deacetylase%2520%2528LpxC%2529%2520against%2520Gram-Negative%2520Bacteria%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2018%26volume%3D18%26spage%3D310%26epage%3D323%26doi%3D10.2174%2F1389557516666161013120253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalinin, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holl, R.</span></span> <span> </span><span class="NLM_article-title">Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor Design</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2379</span>– <span class="NLM_lpage">2430</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413135835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.2174%2F1568026616666160413135835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=27072691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOgs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2379-2430&author=D.+V.+Kalininauthor=R.+Holl&title=Insights+into+the+Zinc-Dependent+Deacetylase+LpxC%3A+Biochemical+Properties+and+Inhibitor+Design&doi=10.2174%2F1568026616666160413135835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor Design</span></div><div class="casAuthors">Kalinin, Dmitrii V.; Holl, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2379-2430</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The bacterial enzyme UDP-3-O-[(R)-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase (LpxC), catalyzing the first committed step of lipid A biosynthesis, represents a promising target in the development of novel antibiotics against Gram-neg. bacteria.  Structure, catalytic reaction mechanism and regulation of the Zn2+-dependent metalloamidase have been intensively investigated.  The enzyme is required for growth and viability of Gram-neg. bacteria, displays no sequence homol. with any mammalian protein, but is highly conserved in Gram-neg. bacteria, thus permitting the development of Gram-neg. selective antibacterial agents with limited off-target effects.  Several small mol. LpxC inhibitors have been developed, like the substrate analog TU-514 (12a), the aryloxazoline L-161,240 (13w), the sulfonamide BB-78485 (23a), the N-aroyl-L-threonine deriv. CHIR-090 (24a), the sulfone-contg. pyridone LpxC-3 (43e), and the uridine-based inhibitor 1-68A (47a), displaying diverse inhibitory and antibacterial activities.  Most of these compds. share a Zn2+-binding hydroxamate moiety attached to a structural element addressing the hydrophobic tunnel or the UDP binding site.  The butadiynyl deriv. ACHN-975 (28) is the first LpxC inhibitor entering clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod_JborvvzXbVg90H21EOLACvtfcHk0lhpBl49B5wFxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOgs7fE&md5=82abc89ee4dab91b95bbb9dabb23f0b3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413135835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413135835%26sid%3Dliteratum%253Aachs%26aulast%3DKalinin%26aufirst%3DD.%2BV.%26aulast%3DHoll%26aufirst%3DR.%26atitle%3DInsights%2520into%2520the%2520Zinc-Dependent%2520Deacetylase%2520LpxC%253A%2520Biochemical%2520Properties%2520and%2520Inhibitor%2520Design%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2379%26epage%3D2430%26doi%3D10.2174%2F1568026616666160413135835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raetz, C. R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fierke, C. A.</span></span> <span> </span><span class="NLM_article-title">UDP-3-<i>O</i>-(<i>R</i>-3-Hydroxymyristoyl)-<i>N</i>-Acetylglucosamine Deacetylase of <i>Escherichia Coli</i> Is a Zinc Metalloenzyme</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1902</span>– <span class="NLM_lpage">1911</span>, <span class="refDoi"> DOI: 10.1021/bi982339s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi982339s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1902-1911&author=J.+E.+Jackmanauthor=C.+R.+H.+Raetzauthor=C.+A.+Fierke&title=UDP-3-O-%28R-3-Hydroxymyristoyl%29-N-Acetylglucosamine+Deacetylase+of+Escherichia+Coli+Is+a+Zinc+Metalloenzyme&doi=10.1021%2Fbi982339s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">UDP-3-O-(R-3-Hydroxymyristoyl)-N-acetylglucosamine Deacetylase of Escherichia coli Is a Zinc Metalloenzyme</span></div><div class="casAuthors">Jackman, Jane E.; Raetz, Christian R. H.; Fierke, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1902-1911</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enzyme UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc deacetylase (LpxC) catalyzes the committed step in the biosynthesis of lipid A and is therefore a potential antibiotic target.  Inhibition of this enzyme by hydroxamate compds. suggested the presence of a metal ion cofactor.  We have investigated the substrate specificity and metal dependence of the deacetylase using spectroscopic and kinetic analyses.  Comparison of the steady-state kinetic parameters for the physiol. substrate UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc and an alternative substrate, UDP-GlcNAc, demonstrates that the ester-linked R-3-hydroxymyristoyl chain increases kcat/KM (5 × 106)-fold.  Metal-chelating reagents, such as dipicolinic acid (DPA) and EDTA, completely inhibit LpxC activity, implicating an essential metal ion.  Plasma emission spectroscopy and colorimetric assays directly demonstrate that purified LpxC contains bound Zn2+.  This Zn2+ can be removed by incubation with DPA, causing a decrease in the LpxC activity that can be restored by subsequent addn. of Zn2+.  However, high concns. of Zn2+ also inhibit LpxC.  Addn. of Co2+, Ni2+, or Mn2+ to apo-LpxC also activates the enzyme to varying degrees while no addnl. activity is obsd. upon the addn. of Cd2+, Ca2+, Mg2+, or Cu2+.  This is consistent with the profile of metals that substitute for catalytic zinc ions in metalloproteinases.  Co2+ ions stimulate LpxC activity maximally at a stoichiometry of 1:1.  These data demonstrate that E. coli LpxC is a metalloenzyme that requires bound Zn2+ for optimal activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoETi4nWY-kpLVg90H21EOLACvtfcHk0lhpBl49B5wFxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFymsw%253D%253D&md5=43e4ad7d68cbbd04a202c898c7bb667a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbi982339s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi982339s%26sid%3Dliteratum%253Aachs%26aulast%3DJackman%26aufirst%3DJ.%2BE.%26aulast%3DRaetz%26aufirst%3DC.%2BR.%2BH.%26aulast%3DFierke%26aufirst%3DC.%2BA.%26atitle%3DUDP-3-O-%2528R-3-Hydroxymyristoyl%2529-N-Acetylglucosamine%2520Deacetylase%2520of%2520Escherichia%2520Coli%2520Is%2520a%2520Zinc%2520Metalloenzyme%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D1902%26epage%3D1911%26doi%3D10.1021%2Fbi982339s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silhavy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S.</span></span> <span> </span><span class="NLM_article-title">The Bacterial Cell Envelope</span>. <i>Cold Spring Harbor Perspect. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">a000414</span> <span class="refDoi"> DOI: 10.1101/cshperspect.a000414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1101%2Fcshperspect.a000414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=20452953" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&author=T.+J.+Silhavyauthor=D.+Kahneauthor=S.+Walker&title=The+Bacterial+Cell+Envelope&doi=10.1101%2Fcshperspect.a000414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a000414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a000414%26sid%3Dliteratum%253Aachs%26aulast%3DSilhavy%26aufirst%3DT.%2BJ.%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DWalker%26aufirst%3DS.%26atitle%3DThe%2520Bacterial%2520Cell%2520Envelope%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2010%26volume%3D2%26doi%3D10.1101%2Fcshperspect.a000414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Surivet, J.-P.</span>; <span class="NLM_string-name">Panchaud, P.</span>; <span class="NLM_string-name">Specklin, J.-L.</span>; <span class="NLM_string-name">Diethelm, S.</span>; <span class="NLM_string-name">Blumstein, A.-C.</span>; <span class="NLM_string-name">Gauvin, J.-C.</span>; <span class="NLM_string-name">Jacob, L.</span>; <span class="NLM_string-name">Masse, F.</span>; <span class="NLM_string-name">Mathieu, G.</span>; <span class="NLM_string-name">Mirre, A.</span>; <span class="NLM_string-name">Schmitt, C.</span>; <span class="NLM_string-name">Lange, R.</span>; <span class="NLM_string-name">Tidten-Luksch, N.</span>; <span class="NLM_string-name">Gnerre, C.</span>; <span class="NLM_string-name">Seeland, S.</span>; <span class="NLM_string-name">Herrmann, C.</span>; <span class="NLM_string-name">Seiler, P.</span>; <span class="NLM_string-name">Enderlin-Paput, M.</span>; <span class="NLM_string-name">Mac Sweeney, A.</span>; <span class="NLM_string-name">Wicki, M.</span>; <span class="NLM_string-name">Hubschwerlen, C.</span>; <span class="NLM_string-name">Ritz, D.</span>; <span class="NLM_string-name">Rueedi, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel Inhibitors of LpxC Displaying Potent in Vitro Activity against Gram-Negative Bacteria</span>,  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01604</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01604" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=J.-P.+Surivet&author=P.+Panchaud&author=J.-L.+Specklin&author=S.+Diethelm&author=A.-C.+Blumstein&author=J.-C.+Gauvin&author=L.+Jacob&author=F.+Masse&author=G.+Mathieu&author=A.+Mirre&author=C.+Schmitt&author=R.+Lange&author=N.+Tidten-Luksch&author=C.+Gnerre&author=S.+Seeland&author=C.+Herrmann&author=P.+Seiler&author=M.+Enderlin-Paput&author=A.+Mac+Sweeney&author=M.+Wicki&author=C.+Hubschwerlen&author=D.+Ritz&author=G.+Rueedi&title=Discovery+of+Novel+Inhibitors+of+LpxC+Displaying+Potent+in+Vitro+Activity+against+Gram-Negative+Bacteria&doi=10.1021%2Facs.jmedchem.9b01604"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01604%26sid%3Dliteratum%253Aachs%26aulast%3DSurivet%26aufirst%3DJ.-P.%26atitle%3DDiscovery%2520of%2520Novel%2520Inhibitors%2520of%2520LpxC%2520Displaying%2520Potent%2520in%2520Vitro%2520Activity%2520against%2520Gram-Negative%2520Bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26doi%3D10.1021%2Facs.jmedchem.9b01604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramite, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcari, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barham, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collantes, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desbonnet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engtrakul, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huband, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knafels, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plummer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishka, D. G.</span></span> <span> </span><span class="NLM_article-title">Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">914</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.1021/jm2014748</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014748" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=914-923&author=M.+F.+Brownauthor=U.+Reillyauthor=J.+A.+Abramiteauthor=J.+T.+Arcariauthor=R.+Oliverauthor=R.+A.+Barhamauthor=Y.+Cheauthor=J.+M.+Chenauthor=E.+M.+Collantesauthor=S.+W.+Chungauthor=C.+Desbonnetauthor=J.+Dotyauthor=M.+Doroskiauthor=J.+J.+Engtrakulauthor=T.+M.+Harrisauthor=M.+Hubandauthor=J.+D.+Knafelsauthor=K.+L.+Leachauthor=S.+Liuauthor=A.+Marfatauthor=A.+Marraauthor=E.+McElroyauthor=M.+Melnickauthor=C.+A.+Menardauthor=J.+I.+Montgomeryauthor=L.+Mullinsauthor=M.+C.+Noeauthor=J.+O%E2%80%99Donnellauthor=J.+Penzienauthor=M.+S.+Plummerauthor=L.+M.+Priceauthor=V.+Shanmugasundaramauthor=C.+Thomaauthor=D.+P.+Uccelloauthor=J.+S.+Warmusauthor=D.+G.+Wishka&title=Potent+Inhibitors+of+LpxC+for+the+Treatment+of+Gram-Negative+Infections&doi=10.1021%2Fjm2014748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections</span></div><div class="casAuthors">Brown, Matthew F.; Reilly, Usa; Abramite, Joseph A.; Arcari, Joel T.; Oliver, Robert; Barham, Rose A.; Che, Ye; Chen, Jinshan Michael; Collantes, Elizabeth M.; Chung, Seung Won; Desbonnet, Charlene; Doty, Jonathan; Doroski, Matthew; Engtrakul, Juntyma J.; Harris, Thomas M.; Huband, Michael; Knafels, John D.; Leach, Karen L.; Liu, Shenping; Marfat, Anthony; Marra, Andrea; McElroy, Eric; Melnick, Michael; Menard, Carol A.; Montgomery, Justin I.; Mullins, Lisa; Noe, Mark. C.; O'Donnell, John; Penzien, Joseph; Plummer, Mark S.; Price, Loren M.; Shanmugasundaram, Veerabahu; Thoma, Christy; Uccello, Daniel P.; Warmus, Joseph S.; Wishka, Donn G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">914-923</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, the synthesis and SAR as well as selectivity, pharmacokinetic, and infection model data for representative analogs of a novel series of potent antibacterial LpxC inhibitors represented by hydroxamic acid I, is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpizPNDLsgyIbVg90H21EOLACvtfcHk0ljYzQQuJqracQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7rE&md5=fda4af453d09a4baa25cac35f69f5ac3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm2014748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014748%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DReilly%26aufirst%3DU.%26aulast%3DAbramite%26aufirst%3DJ.%2BA.%26aulast%3DArcari%26aufirst%3DJ.%2BT.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DBarham%26aufirst%3DR.%2BA.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DCollantes%26aufirst%3DE.%2BM.%26aulast%3DChung%26aufirst%3DS.%2BW.%26aulast%3DDesbonnet%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%26aulast%3DDoroski%26aufirst%3DM.%26aulast%3DEngtrakul%26aufirst%3DJ.%2BJ.%26aulast%3DHarris%26aufirst%3DT.%2BM.%26aulast%3DHuband%26aufirst%3DM.%26aulast%3DKnafels%26aufirst%3DJ.%2BD.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMarfat%26aufirst%3DA.%26aulast%3DMarra%26aufirst%3DA.%26aulast%3DMcElroy%26aufirst%3DE.%26aulast%3DMelnick%26aufirst%3DM.%26aulast%3DMenard%26aufirst%3DC.%2BA.%26aulast%3DMontgomery%26aufirst%3DJ.%2BI.%26aulast%3DMullins%26aufirst%3DL.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%26aulast%3DPenzien%26aufirst%3DJ.%26aulast%3DPlummer%26aufirst%3DM.%2BS.%26aulast%3DPrice%26aufirst%3DL.%2BM.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DThoma%26aufirst%3DC.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26atitle%3DPotent%2520Inhibitors%2520of%2520LpxC%2520for%2520the%2520Treatment%2520of%2520Gram-Negative%2520Infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D914%26epage%3D923%26doi%3D10.1021%2Fjm2014748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramite, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collantes, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desbonnet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engtrakul, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huband, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knafels, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitton-Fry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plummer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaras, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishka, D. G.</span></span> <span> </span><span class="NLM_article-title">Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1662</span>– <span class="NLM_lpage">1670</span>, <span class="refDoi"> DOI: 10.1021/jm2014875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1662-1670&author=J.+I.+Montgomeryauthor=M.+F.+Brownauthor=U.+Reillyauthor=L.+M.+Priceauthor=J.+A.+Abramiteauthor=J.+Arcariauthor=R.+Barhamauthor=Y.+Cheauthor=J.+M.+Chenauthor=S.+W.+Chungauthor=E.+M.+Collantesauthor=C.+Desbonnetauthor=M.+Doroskiauthor=J.+Dotyauthor=J.+J.+Engtrakulauthor=T.+M.+Harrisauthor=M.+Hubandauthor=J.+D.+Knafelsauthor=K.+L.+Leachauthor=S.+Liuauthor=A.+Marfatauthor=L.+McAllisterauthor=E.+McElroyauthor=C.+A.+Menardauthor=M.+Mitton-Fryauthor=L.+Mullinsauthor=M.+C.+Noeauthor=J.+O%E2%80%99Donnellauthor=R.+Oliverauthor=J.+Penzienauthor=M.+Plummerauthor=V.+Shanmugasundaramauthor=C.+Thomaauthor=A.+P.+Tomarasauthor=D.+P.+Uccelloauthor=A.+Vazauthor=D.+G.+Wishka&title=Pyridone+Methylsulfone+Hydroxamate+LpxC+Inhibitors+for+the+Treatment+of+Serious+Gram-Negative+Infections&doi=10.1021%2Fjm2014875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections</span></div><div class="casAuthors">Montgomery, Justin I.; Brown, Matthew F.; Reilly, Usa; Price, Loren M.; Abramite, Joseph A.; Arcari, Joel; Barham, Rose; Che, Ye; Chen, Jinshan Michael; Chung, Seung Won; Collantes, Elizabeth M.; Desbonnet, Charlene; Doroski, Matthew; Doty, Jonathan; Engtrakul, Juntyma J.; Harris, Thomas M.; Huband, Michael; Knafels, John D.; Leach, Karen L.; Liu, Shenping; Marfat, Anthony; McAllister, Laura; McElroy, Eric; Menard, Carol A.; Mitton-Fry, Mark; Mullins, Lisa; Noe, Mark C.; O'Donnell, John; Oliver, Robert; Penzien, Joseph; Plummer, Mark; Shanmugasundaram, Veerabahu; Thoma, Christy; Tomaras, Andrew P.; Uccello, Daniel P.; Vaz, Alfin; Wishka, Donn G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1662-1670</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and biol. activity of a new series of LpxC inhibitors represented by pyridone methylsulfone hydroxamate 2a (I) is presented.  Members of this series have improved soly. and free fraction when compared to compds. in the previously described biphenyl methylsulfone hydroxamate series, and they maintain superior Gram-neg. antibacterial activity to comparator agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgNGd-bEXEabVg90H21EOLACvtfcHk0lgLsPgKHpHGWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVyjtw%253D%253D&md5=f2410aae177b2fa24d8da72942b95564</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm2014875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014875%26sid%3Dliteratum%253Aachs%26aulast%3DMontgomery%26aufirst%3DJ.%2BI.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DReilly%26aufirst%3DU.%26aulast%3DPrice%26aufirst%3DL.%2BM.%26aulast%3DAbramite%26aufirst%3DJ.%2BA.%26aulast%3DArcari%26aufirst%3DJ.%26aulast%3DBarham%26aufirst%3DR.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DChung%26aufirst%3DS.%2BW.%26aulast%3DCollantes%26aufirst%3DE.%2BM.%26aulast%3DDesbonnet%26aufirst%3DC.%26aulast%3DDoroski%26aufirst%3DM.%26aulast%3DDoty%26aufirst%3DJ.%26aulast%3DEngtrakul%26aufirst%3DJ.%2BJ.%26aulast%3DHarris%26aufirst%3DT.%2BM.%26aulast%3DHuband%26aufirst%3DM.%26aulast%3DKnafels%26aufirst%3DJ.%2BD.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMarfat%26aufirst%3DA.%26aulast%3DMcAllister%26aufirst%3DL.%26aulast%3DMcElroy%26aufirst%3DE.%26aulast%3DMenard%26aufirst%3DC.%2BA.%26aulast%3DMitton-Fry%26aufirst%3DM.%26aulast%3DMullins%26aufirst%3DL.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DPenzien%26aufirst%3DJ.%26aulast%3DPlummer%26aufirst%3DM.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DThoma%26aufirst%3DC.%26aulast%3DTomaras%26aufirst%3DA.%2BP.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DVaz%26aufirst%3DA.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26atitle%3DPyridone%2520Methylsulfone%2520Hydroxamate%2520LpxC%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Serious%2520Gram-Negative%2520Infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1662%26epage%3D1670%26doi%3D10.1021%2Fjm2014875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomaras, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carifa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desbonnet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidem, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. P.</span></span> <span> </span><span class="NLM_article-title">LpxC Inhibitors as New Antibacterial Agents and Tools for Studying Regulation of Lipid A Biosynthesis in Gram-Negative Pathogens</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e01551-14</span> <span class="refDoi"> DOI: 10.1128/mBio.01551-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1128%2FmBio.01551-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=25271285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=A.+P.+Tomarasauthor=C.+J.+McPhersonauthor=M.+Kuhnauthor=A.+Carifaauthor=L.+Mullinsauthor=D.+Georgeauthor=C.+Desbonnetauthor=T.+M.+Eidemauthor=J.+I.+Montgomeryauthor=M.+F.+Brownauthor=U.+Reillyauthor=A.+A.+Millerauthor=J.+P.+O%E2%80%99Donnell&title=LpxC+Inhibitors+as+New+Antibacterial+Agents+and+Tools+for+Studying+Regulation+of+Lipid+A+Biosynthesis+in+Gram-Negative+Pathogens&doi=10.1128%2FmBio.01551-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FmBio.01551-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01551-14%26sid%3Dliteratum%253Aachs%26aulast%3DTomaras%26aufirst%3DA.%2BP.%26aulast%3DMcPherson%26aufirst%3DC.%2BJ.%26aulast%3DKuhn%26aufirst%3DM.%26aulast%3DCarifa%26aufirst%3DA.%26aulast%3DMullins%26aufirst%3DL.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DDesbonnet%26aufirst%3DC.%26aulast%3DEidem%26aufirst%3DT.%2BM.%26aulast%3DMontgomery%26aufirst%3DJ.%2BI.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DReilly%26aufirst%3DU.%26aulast%3DMiller%26aufirst%3DA.%2BA.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DLpxC%2520Inhibitors%2520as%2520New%2520Antibacterial%2520Agents%2520and%2520Tools%2520for%2520Studying%2520Regulation%2520of%2520Lipid%2520A%2520Biosynthesis%2520in%2520Gram-Negative%2520Pathogens%26jtitle%3DmBio%26date%3D2014%26volume%3D5%26doi%3D10.1128%2FmBio.01551-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gad, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spainhour, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemake, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stricker-Krongrad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downing, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seals, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eagle, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polhamus, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J.</span></span> <span> </span><span class="NLM_article-title">Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species with Notes on Methods to Improve Utility</span>. <i>Int. J. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1177/1091581815622442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1177%2F1091581815622442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=26755718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A280%3ADC%252BC28rpt1emtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=95-178&author=S.+C.+Gadauthor=C.+B.+Spainhourauthor=C.+Shoemakeauthor=D.+R.+Pallmanauthor=A.+Stricker-Krongradauthor=P.+A.+Downingauthor=R.+E.+Sealsauthor=L.+A.+Eagleauthor=K.+Polhamusauthor=J.+Daly&title=Tolerable+Levels+of+Nonclinical+Vehicles+and+Formulations+Used+in+Studies+by+Multiple+Routes+in+Multiple+Species+with+Notes+on+Methods+to+Improve+Utility&doi=10.1177%2F1091581815622442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species With Notes on Methods to Improve Utility</span></div><div class="casAuthors">Gad Shayne Cox; Eagle Leslie Anne; Spainhour Charles B; Pallman Danielle R Stackhouse; Shoemake Catherine; Stricker-Krongrad Alain; Downing Philip A; Seals Richard E; Polhamus Kara; Daly Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">International journal of toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-178</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Formulation of nonclinical evaluations is a challenge, with the fundamental need to achieve multiples of the clinical exposure complicated by differences in species and routes of administration-specific tolerances, depending on concentrations, volumes, dosing regimen, duration of each administration, and study duration.  Current practice to approach these differences is based on individual experience and scattered literature with no comprehensive data source (the most notable exception being our 2006 publication on this same subject).  Lack of formulation tolerance data results in excessive animal use, unplanned delays in the evaluation and development of drugs, and vehicle-dependent results.  A consulting firm, a chemical company, and 4 contract research organizations conducted a rigorous data mining operation of vehicle data from studies dating from 1991 to 2015, enhancing the data from this author's 2006 publication (3 of the six 2015 contributors were also 2006 contributors).  Additional data were found in the published literature.  The results identified 108 single-component vehicles (and 305 combination formulations) used in more than 1,040 studies across multiple species (dog, primate, rat, mouse, rabbit, guinea pig, minipig, pig, chick embryo, and cat) by multiple routes for a wide range of study durations.  The tabulated data include maximum tolerated use levels by species, route, duration of study, dose-limiting toxicity where reported, review of the available literature on each vehicle, guidance on syringe selection, volume and pH limits by route with basic guidance on nonclinical formulation development, and guidance on factors to be considered in nonclinical route selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGnyl3PdyDRJPq5LRczm8ffW6udTcc2eaG1-oMfx53Bbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rpt1emtw%253D%253D&md5=797586f4df5a222f3f78da7495ec1396</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1177%2F1091581815622442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1091581815622442%26sid%3Dliteratum%253Aachs%26aulast%3DGad%26aufirst%3DS.%2BC.%26aulast%3DSpainhour%26aufirst%3DC.%2BB.%26aulast%3DShoemake%26aufirst%3DC.%26aulast%3DPallman%26aufirst%3DD.%2BR.%26aulast%3DStricker-Krongrad%26aufirst%3DA.%26aulast%3DDowning%26aufirst%3DP.%2BA.%26aulast%3DSeals%26aufirst%3DR.%2BE.%26aulast%3DEagle%26aufirst%3DL.%2BA.%26aulast%3DPolhamus%26aufirst%3DK.%26aulast%3DDaly%26aufirst%3DJ.%26atitle%3DTolerable%2520Levels%2520of%2520Nonclinical%2520Vehicles%2520and%2520Formulations%2520Used%2520in%2520Studies%2520by%2520Multiple%2520Routes%2520in%2520Multiple%2520Species%2520with%2520Notes%2520on%2520Methods%2520to%2520Improve%2520Utility%26jtitle%3DInt.%2520J.%2520Toxicol.%26date%3D2016%26volume%3D35%26spage%3D95%26epage%3D178%26doi%3D10.1177%2F1091581815622442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neervannan, S.</span></span> <span> </span><span class="NLM_article-title">Preclinical Formulations for Discovery and Toxicology: Physicochemical Challenges</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1517/17425255.2.5.715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1517%2F17425255.2.5.715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=17014391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtValtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=715-731&author=S.+Neervannan&title=Preclinical+Formulations+for+Discovery+and+Toxicology%3A+Physicochemical+Challenges&doi=10.1517%2F17425255.2.5.715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical formulations for discovery and toxicology: physicochemical challenges</span></div><div class="casAuthors">Neervannan, Seshadri</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">715-731</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Formulations play a key role in assessing the biol. properties of a mol. during drug discovery.  Maximising exposure is the primary objective in early animal experimentation, so that the pharmacokinetics, pharmacodynamics and toxicol. signals can be put into context with the biol. response to specific targets.  Consistency in the exposure is also a key aspect, and effective formulation and drug delivery strategies are important to achieve this.  Diversity in the physiol. between various animal species, routes of administration and limitations posed by specific pharmacol. models make formulation development that much more challenging.  Poor physicochem. properties of compds. in the early stages need to be kept under consideration while screening for formulation vehicles.  This review captures the various challenges posed at different stages of drug discovery for formulation of a compd. to dose in animals.  Approaches to formulations for various routes of administration are discussed.  Limitations posed by the goals for various animal studies such as early efficacy studies, pharmacokinetic studies and toxicol. studies are identified and some strategies are proposed.  Physicochem. characterizations that are needed to select formulation vehicles as well as to identify potential issues are suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnqg8ruyksJ7Vg90H21EOLACvtfcHk0ljadx86yusnfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtValtbvE&md5=4946da3cdb43f2394dd9c5e24c7dc5ba</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F17425255.2.5.715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2.5.715%26sid%3Dliteratum%253Aachs%26aulast%3DNeervannan%26aufirst%3DS.%26atitle%3DPreclinical%2520Formulations%2520for%2520Discovery%2520and%2520Toxicology%253A%2520Physicochemical%2520Challenges%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2006%26volume%3D2%26spage%3D715%26epage%3D731%26doi%3D10.1517%2F17425255.2.5.715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of Fluorine in Medicinal Chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+Fluorine+in+Medicinal+Chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0li7ew7cvC4ELg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520Fluorine%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wuitschik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreira, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrilla, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span> <span> </span><span class="NLM_article-title">Oxetanes in Drug Discovery: Structural and Synthetic Insights</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3227</span>– <span class="NLM_lpage">3246</span>, <span class="refDoi"> DOI: 10.1021/jm9018788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9018788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3227-3246&author=G.+Wuitschikauthor=E.+M.+Carreiraauthor=B.+Wagnerauthor=H.+Fischerauthor=I.+Parrillaauthor=F.+Schulerauthor=M.+Rogers-Evansauthor=K.+Muller&title=Oxetanes+in+Drug+Discovery%3A+Structural+and+Synthetic+Insights&doi=10.1021%2Fjm9018788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Oxetanes in Drug Discovery: Structural and Synthetic Insights</span></div><div class="casAuthors">Wuitschik, Georg; Carreira, Erick M.; Wagner, Bjorn; Fischer, Holger; Parrilla, Isabelle; Schuler, Franz; Rogers-Evans, Mark; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3227-3246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of oxetanes as replacements for gem-di-Me or carbonyl groups and their effects on the aq. soly., lipophilicity, metabolic stability, and conformation for various compds. are studied; methods for the prepn. of a variety of substituted oxetanes are given.  The magnitude of changes in properties and in metabolic stability with oxetane substitution depends on the structural context; for example, substitution of a gem-di-Me group with an oxetane, aq. soly. may increase by a factor of 4 to more than 4000 while reducing the rate of metabolic degrdn. in most cases.  Incorporation of an oxetane into an aliph. chain increases in some cases the preference for synclinal conformations rather than antiplanar conformations of the chain.  Spirocyclic oxetanes such as an oxazaspiroheptane resemble commonly used fragments in drug discovery, such as morpholines, and in some cases increase aq. soly. more effectively than morpholines.  An improved chemoselective oxidn. of 3-oxetanol to 3-oxetanone is disclosed; olefination of 3-oxetanone by a variety of methods yields alkylideneoxetanes I [R = (EtO)2P(:O), OHC, O2N, EtO2C, NC, PhO2S, MeCO, 1-(4-chlorophenyl)-1-cyclobutanecarbonyl].  I (R = EtO2C, OHC, O2N) undergo addn. reactions with nucleophiles such as amines, carbonyl compds., and arylboronic acids to give oxetanes such as II.  The crystal structures of a variety of oxetanes are detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYbJqJGrlPJrVg90H21EOLACvtfcHk0li7ew7cvC4ELg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D&md5=e95742d38e933c2fb0d76d638ccc773c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm9018788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9018788%26sid%3Dliteratum%253Aachs%26aulast%3DWuitschik%26aufirst%3DG.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DParrilla%26aufirst%3DI.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DOxetanes%2520in%2520Drug%2520Discovery%253A%2520Structural%2520and%2520Synthetic%2520Insights%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3227%26epage%3D3246%26doi%3D10.1021%2Fjm9018788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahne, D.</span></span> <span> </span><span class="NLM_article-title">On the Essentiality of Lipopolysaccharide to Gram-Negative Bacteria</span>. <i>Curr. Opin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1016/j.mib.2013.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=10.1016%2Fj.mib.2013.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=24148302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=779-785&author=G.+Zhangauthor=T.+C.+Meredithauthor=D.+Kahne&title=On+the+Essentiality+of+Lipopolysaccharide+to+Gram-Negative+Bacteria&doi=10.1016%2Fj.mib.2013.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">On the essentiality of lipopolysaccharide to Gram-negative bacteria</span></div><div class="casAuthors">Zhang, Ge; Meredith, Timothy C.; Kahne, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">779-785</span>CODEN:
                <span class="NLM_cas:coden">COMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1369-5274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Lipopolysaccharide is a highly acylated saccharolipid located on the outer leaflet of the outer membrane of Gram-neg. bacteria.  Lipopolysaccharide is crit. to maintaining the barrier function preventing the passive diffusion of hydrophobic solutes such as antibiotics and detergents into the cell.  Lipopolysaccharide has been considered an essential component for outer membrane biogenesis and cell viability based on pioneering studies in the model Gram-neg. organisms Escherichia coli and Salmonella.  With the isolation of lipopolysaccharide-null mutants in Neisseria meningitidis, Moraxella catarrhalis, and most recently in Acinetobacter baumannii, it has become increasingly apparent that lipopolysaccharide is not an essential outer membrane building block in all organisms.  We suggest the accumulation of toxic intermediates, misassembly of essential outer membrane porins, and outer membrane stress response pathways that are activated by mislocalized lipopolysaccharide may collectively contribute to the obsd. strain-dependent essentiality of lipopolysaccharide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKMIl8joRZXbVg90H21EOLACvtfcHk0lheNe-EavIveA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqtLfE&md5=3dfe6c82b93a0f6744da022718ca1c5d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.mib.2013.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mib.2013.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DMeredith%26aufirst%3DT.%2BC.%26aulast%3DKahne%26aufirst%3DD.%26atitle%3DOn%2520the%2520Essentiality%2520of%2520Lipopolysaccharide%2520to%2520Gram-Negative%2520Bacteria%26jtitle%3DCurr.%2520Opin.%2520Microbiol.%26date%3D2013%26volume%3D16%26spage%3D779%26epage%3D785%26doi%3D10.1016%2Fj.mib.2013.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span> <span> </span><span class="NLM_article-title">Bulky Trialkylsilyl Acetylenes in the Cadiot-Chodkiewicz Cross-Coupling Reaction</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">6841</span>– <span class="NLM_lpage">6844</span>, <span class="refDoi"> DOI: 10.1021/jo025745x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo025745x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsFSqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=6841-6844&author=J.+P.+Marinoauthor=H.+N.+Nguyen&title=Bulky+Trialkylsilyl+Acetylenes+in+the+Cadiot-Chodkiewicz+Cross-Coupling+Reaction&doi=10.1021%2Fjo025745x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Bulky Trialkylsilyl Acetylenes in the Cadiot-Chodkiewicz Cross-Coupling Reaction</span></div><div class="casAuthors">Marino, Joseph P.; Nguyen, Hanh Nho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6841-6844</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bulky trialkylsilyl-protected alkynes such as triethylsilyl (TES), tert-butyldimethylsilyl (TBS), and triisopropylsilyl (TIPS) acetylenes underwent the Cadiot-Chodkiewicz cross-coupling reaction with different bromoalkynes to form a variety of synthetically useful unsym. diynes in good yields.  The diyne alc. TESC≡CC≡CCH2OH was transformed regio- and stereoselectively into enynes by hydrotelluration, carbometalation, and redn. reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVGUUQOAdK2LVg90H21EOLACvtfcHk0lheNe-EavIveA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsFSqu74%253D&md5=a74f5a735db24d2e4ad34929b6637c61</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo025745x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025745x%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26atitle%3DBulky%2520Trialkylsilyl%2520Acetylenes%2520in%2520the%2520Cadiot-Chodkiewicz%2520Cross-Coupling%2520Reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D6841%26epage%3D6844%26doi%3D10.1021%2Fjo025745x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapoux, G.</span>; <span class="NLM_string-name">Gauvin, J.-C.</span>; <span class="NLM_string-name">Panchaud, P.</span>; <span class="NLM_string-name">Specklin, J.-L.</span>; <span class="NLM_string-name">Surivet, J.-P.</span>; <span class="NLM_string-name">Schmitt, C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Dihydropyrrolo[1,2-<i>c</i>]imidazol-3-one Derivatives Useful as Antibacterial Agents</span>. PCT International Patent WO <span class="NLM_patent">WO 2015132228 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=G.+Chapoux&author=J.-C.+Gauvin&author=P.+Panchaud&author=J.-L.+Specklin&author=J.-P.+Surivet&author=C.+Schmitt&title=Preparation+of+Dihydropyrrolo%5B1%2C2-c%5Dimidazol-3-one+Derivatives+Useful+as+Antibacterial+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChapoux%26aufirst%3DG.%26atitle%3DPreparation%2520of%2520Dihydropyrrolo%255B1%252C2-c%255Dimidazol-3-one%2520Derivatives%2520Useful%2520as%2520Antibacterial%2520Agents%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blumstein, A.-C.</span>; <span class="NLM_string-name">Chapoux, G.</span>; <span class="NLM_string-name">Jacob, L.</span>; <span class="NLM_string-name">Masse, F.</span>; <span class="NLM_string-name">Mirre, A.</span>; <span class="NLM_string-name">Panchaud, P.</span>; <span class="NLM_string-name">Schmitt, C.</span>; <span class="NLM_string-name">Surivet, J.-P.</span>; <span class="NLM_string-name">Specklin, J.-L.</span></span> <span> </span><span class="NLM_article-title">Substituted 1,2-Dihydro-3<i>H</i>-pyrrolo[1,2-<i>c</i>]imidazol-3-one Antibacterial Compounds</span>. PCT International Patent WO <span class="NLM_patent">WO 2017037221 A1</span>, 2017.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Blumstein%2C+A.-C.%3B+Chapoux%2C+G.%3B+Jacob%2C+L.%3B+Masse%2C+F.%3B+Mirre%2C+A.%3B+Panchaud%2C+P.%3B+Schmitt%2C+C.%3B+Surivet%2C+J.-P.%3B+Specklin%2C+J.-L.+Substituted+1%2C2-Dihydro-3H-pyrrolo%5B1%2C2-c%5Dimidazol-3-one+Antibacterial+Compounds.+PCT+International+Patent+WO+WO+2017037221+A1%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlumstein%26aufirst%3DA.-C.%26atitle%3DSubstituted%25201%252C2-Dihydro-3H-pyrrolo%255B1%252C2-c%255Dimidazol-3-one%2520Antibacterial%2520Compounds" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaninger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karge, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abele, S.</span></span> <span> </span><span class="NLM_article-title">Scalable Process for the Production of a Highly Energetic Bromoacetylene Building Block</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.8b00223</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.8b00223" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWjtLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=1409-1418&author=P.+Kohlerauthor=M.+Schwaningerauthor=A.+Stutzauthor=R.+Kargeauthor=S.+Abele&title=Scalable+Process+for+the+Production+of+a+Highly+Energetic+Bromoacetylene+Building+Block&doi=10.1021%2Facs.oprd.8b00223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Scalable Process for the Production of a Highly Energetic Bromoacetylene Building Block</span></div><div class="casAuthors">Kohler, Philipp; Schwaninger, Mischa; Stutz, Alfred; Karge, Reinhard; Abele, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1409-1418</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-(Bromoethynyl)azetidine is a highly energetic building block (decompn. energy up to -1800 J g-1) that was required in multikilogram quantities for the prodn. of an API.  The development of a four-step, fully telescoped, scalable sequence for its synthesis is described, along with a detailed safety study of the corresponding hydrochloride salt in order to det. the potential explosive properties and transport classification.  A screen of counterions identified the (+)-camphorsulfonic acid salt as the most suitable form for mitigation of the energetic properties, as judged by differential scanning calorimetry (onset 182 °C, energy -876 J g-1).  This case study demonstrates how a daunting chem. structure can be "tamed" by chem. process development, tuning of mol. properties, and thorough safety investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogkk3IgDa0tbVg90H21EOLACvtfcHk0lhoORep_E_AjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWjtLjF&md5=6ba3c82a50658ce2961378d485286b2d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.8b00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.8b00223%26sid%3Dliteratum%253Aachs%26aulast%3DKohler%26aufirst%3DP.%26aulast%3DSchwaninger%26aufirst%3DM.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DKarge%26aufirst%3DR.%26aulast%3DAbele%26aufirst%3DS.%26atitle%3DScalable%2520Process%2520for%2520the%2520Production%2520of%2520a%2520Highly%2520Energetic%2520Bromoacetylene%2520Building%2520Block%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2018%26volume%3D22%26spage%3D1409%26epage%3D1418%26doi%3D10.1021%2Facs.oprd.8b00223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i56"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01605">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_02831"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01605?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01605</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental details on preparation of recombinant Pae and Eco LpxC proteins; DSF measurement; MIC testing; log <i>D</i>, p<i>K</i><sub>a</sub>, and solubility determination; formulation trials; neutropenic murine thigh infection model; pharmacokinetics in the mouse and in the rat; MICs against PAO1 and PA2616 strains; graphical representation of in vivo efficacy and descriptive statistics; preparation of compounds <b>33a</b>–<b>r</b> and <b>14</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01605/suppl_file/jm9b01605_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01605/suppl_file/jm9b01605_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01605/suppl_file/jm9b01605_si_001.pdf">jm9b01605_si_001.pdf (1.87 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01605/suppl_file/jm9b01605_si_002.csv">jm9b01605_si_002.csv (4.23 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01605&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01605%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-1%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01605" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679911854cd13cdc","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
